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1. Introduction  
1.1 The nuclear envelope 
In the cell, the genome is physically separated from the cytoplasm by the nuclear envelope 
(NE) (Fig. 1.1). The nuclear envelope contains a double membrane, the inner nuclear 
membrane (INM) and the outer nuclear membrane (ONM) that connect at nuclear pores and 
form surround the lumen (perinuclear space, PNS) which is the continuation of the 
endoplasmic reticulum (ER) lumen (Razafsky et al., 2014). While the ONM is an extension of 
the rough ER and studded with ribosomes, the INM is lacking ribosomes and includes over 60 
putative transmembrane proteins which insert in the INM and interact through their 
nucleoplasmic domains with the nuclear lamina and/or chromatin (Schirmer et al., 2003). 
The ONM and INM dynamically fuse to create pores and the nuclear pore complexes (NPCs) 
are embedded inside (Capelson et al., 2010). The NE serves as selective channels for 
bidirectional transport (Aitchison and Rout, 2012; Grossman et al., 2012). Small molecules, 
less than ~40 kDa, may pass through the NE unimpededly. In contrast, larger molecules 
require specific receptors to enter or exit the nucleus (Fried and Kutay, 2003). 
 
 
Figure 1.1 Organization of the nuclear envelope (modified from Stewart et al., 2007). The nuclear envelope 
consists of INM and ONM. Some selected INM proteins (LAP1, LAP2 and LBR) are shown which interact with 
HP1 and BAF to associate with chromatin. Lamins, the intermediate filament protein meshwork of the nucleus, 
and NPCs, formed by the ONM and INM fusion, are also shown. The LINC complex built by nesprin proteins in 
the ONM and SUN proteins in the INM is recognized as the linker of nucleoskeleton and cytoskeleton (Stewart 
et al., 2007). 
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1.1.1 The LINC complex 
In eukaryotic cells, the nucleus is mechanically linked to the cytoskeleton by the LINC 
(Linker of Nucleoskeleton and Cytoskeleton) complex (Fig. 1.2). It is composed of SUN 
(Sad1 and UNC-84) domain protein in the INM and KASH (Klarsicht, ANC-1, and Syne 
homology) domain protein in the ONM. In the PNS, SUN and KASH domain proteins 
directly interact with each other to form a linker between the nucleo- and cytoskeleton 
through the NE. This interaction anchors the KASH domain protein in the ONM and prevents 
its diffusion into the ER. The N-terminus of KASH domain protein connects with the 
cytoplasm by interactions with different cytoskeletal proteins. Meanwhile, the N-terminus of 
SUN domain protein associates with the nucleoskeleton by interactions with A-type lamins, 
chromatin-binding proteins, and so on. These connections enable the LINC complex to 
mediate the communication and force transduction between nucleo- and cytoplasm. Briefly, 
LINC complex plays an important role in mechanical action and crosstalk between both sides 
of the NE (Chang et al., 2015; Rothballer and Kutay, 2013). 
  
Figure 1.2 Schematic representation of the LINC complex (Chang et al., 2015). The LINC complex is 
composed of SUN domain protein and KASH domain protein. The homotrimeric SUN domains act as a tailored 
platform to provide the interaction with three KASH peptides. The N-termini of SUN protein and KASH protein 
interact with different elements on both sides of the NE respectively, enabling LINC complex to mediate the 
communication and force transduction between nucleo- and cytoplasm (Chang et al., 2015; Sosa et al., 2013). 
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1.1.1.1 SUN domain proteins 
The INM components of LINC complexes are the SUN domain proteins. The SUN domain 
proteins are conserved type-II INM proteins and consist of N-terminus, coiled-coiled, 
transmembrane and SUN domain at the C-terminus in the lumen of NE (Mejat and Misteli, 
2010; Tzur et al., 2006; Worman and Gundersen, 2006). SUN (Sad1 and UNC-84) proteins 
were originally identified in S. pombe (Sad1) (Hagan and Yanagida, 1995) and 
Caenorhabditis elegans (UNC-84) (Malone et al., 1999). Their remarkable feature is a ~200 
amino acids containing domain at the C-terminus (Hagan and Yanagida, 1995).  
Further, this region is named as SUN domain (Sad1-Unc84 homology, PFAM family 
PF03856), and found to be evolutionarily highly conserved from yeast to mammals: Mps3 in 
S. cerevisiae (Jaspersen et al., 2006); Sad1 in S. pombe (Hagan and Yanagida, 1995); Unc-84 
and SUN1/MTF-1 (Matefin) in C. elegans (Malone et al., 1999) and Klaroid in D. 
melanogaster (Kracklauer et al., 2007) (Fig 1.3). So far, several SUN domain proteins have 
been reported in mammals including SUN1, SUN2, SUN3, SUN4 (SPAG4) and SUN5 
(SPAG4L). The expression level of SUN1 and SUN2 are extensive in all tissues. However, 
for SUN3, the expression is special in testes and localization is restricted to the ER (Crisp et 
al., 2006). Similarly, SUN4 (SPAG4) is only found in spermatids, pancreas and testes (Shao 
et al., 1999) and SUN5 (SPAG4L) is uniquely expressed in testis as well (Frohnert et al., 
2011).  
Due to the aim of this project, we will emphasize the roles of SUN1 and SUN2 in mammals. 
The largest member of the SUN domain family SUN1 contains 812 amino acids 
corresponding to a molecular weight of ~90 kD, while SUN2 contains 717 amino acids with a 
molecular weight of ~80 kD. SUN1 and SUN2 display high homology up to 64% (Haque et 
al., 2006).  
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Figure 1.3 Evolutionarily highly conserved SUN domain proteins from yeast to mammals (Rothballer et al., 
2013). All the SUN domain proteins contain the N-terminus (yellow) in the nucleoplasm, one transmembrane 
region (red) in the INM, and both the coiled coil region (blue) and the conserved SUN domain (orange) in the 
lumen of the NE/ER. 
 
1.1.1.2 KASH domain proteins 
The ONM components of the LINC complexes are the KASH domain proteins. The SUN 
domain interacts directly with the KASH domain in the PNS. The KASH (Klarsicht/Anc-1, 
Syne Homology, PFAM family PF10541) domain is a transmembrane domain of ~60 amino 
acids followed by a luminal C-terminal extension of ~30 amino acids (Razafsky et al., 2014). 
Like SUN proteins, KASH domain proteins are also evolutionarily conserved and have been 
identified in S. pombe (Kms1/2), S. cerevisiae (Mps2), C. elegans (ZYG-12, UNC-83, ANC-1 
and KDP-1), D. melanogaster (Klarsicht and Msp-300) and mammals (nesprin 1-4 and 
KASH5) (Mejat and Misteli, 2010; Morimoto et al., 2012).  
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In mammals, the KASH domain proteins are composed of nesprins 1-4 and KASH5 (Figure 
1.4) encoded by five independent genes (SYNE1-5). Nesprins (nuclear envelope spectrin-
repeat proteins) have many isoforms due to alternative splicing and transcription initiation 
(Apel et al., 2000; Morimoto et al., 2012; Roux et al., 2009; Wilhelmsen et al., 2005; Zhang et 
al., 2002). The expression levels of nesprin-1, -2 and -3 are comparatively high in all tissues. 
However, for nesprin-4, the expression is limited to secretory epithelial cells and hair cells of 
the inner ear (Roux et al., 2009), and KASH5 is specifically found in testis related to meiosis 
(Morimoto et al., 2012).  
 
Figure 1.4 Overview of  the KASH domain proteins and their interaction partners (Chang et al., 2015). 
The schematic of KASH domain proteins in mammals and C. elegans are shown. The binding regions for their 
interaction partners are indicated by the lines under the KASH proteins. “Unmapped” means the binding sites of 
these partners have not been identified. The CH domains in the giant KASH proteins (nesprin-1G, nesprin-2G, 
and ANC-1) is responsible for F-actin, microtubule motors, and signaling proteins binding. The interaction 
partners of some KASH domain missing isoforms are indicated in blue. 
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1.1.2 Nuclear pore complexes (NPCs) 
The INM and ONM of the NE join and bend to form pores within which the NPCs embed 
(Wente and Rout, 2010). NPCs are large protein assemblies (~125 nm in diameter) with a 
molecular weight of 125 MDa in metazoa and 60 MDa in yeast and are constructed from 
multiple copies of ~30 different proteins named nucleoporins (Nups) (Kohler and Hurt, 2007).  
The NPC is an eightfold symmetrical cylindrical structure consisting of eight spokes 
surrounding a central tube and can be divided into three parts: the nuclear face, the central 
channel and the cytoplasmic face (Oeffinger and Zenklusen, 2012). The biggest part of the 
NPC is its central channel. Surrounding the central tube there are three main rings: two outer 
rings and one inner ring. The inner ring is located at the NPC’s equator, and the two outer 
rings are separated by the inner ring at the nucleo- and cytoplasmic side, respectively. Both 
the nuclear side and the cytoplasmic side contain asymmetrical filamentous structures which 
link the NPC central channel to its molecular environment either in the nucleus or in the 
cytoplasm (Strambio-De-Castillia et al., 2010). According to the structure of the NPC, the 
Nups can be subdivided into four types: transmembrane Nups, core scaffold Nups, linker 
Nups and FG (Phe-Gly) Nups (Strambio-De-Castillia et al., 2010) (Figure 1.5).  
 
 
Figure 1.5 Schematic of the NPC (Strambio-De-Castillia et al., 2010). Each NPC is a symmetrical cylindrical 
structure comprising of eight spokes surrounding a central tube. The transmembrane ring structure made of 
transmembrane Nups anchor the NPC to the nuclear envelope. The core scaffold including the inner and the 
outer ring is constructed by the core scaffold Nups. The central FG (Phe-Gly) Nups locate at the surface of the 
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central tube from the nuclear to the cytoplasmic face. The linker Nups provide a connection between these FG 
Nups and the core scaffold of the NPC. Cytoplasmic filaments and the basket also made of FG Nups are the 
NPC-associated peripheral structures. For yeast and vertebrates, all Nups which have been identified in each 
NPC substructure are shown.  
 
1.1.3 Lamins and other nuclear envelope proteins 
In metazoan, the lamina is comprised of intermediate filament proteins called Lamins which 
are attached to the nuclear side of the INM (Brachner and Foisner, 2011) and are the major 
components of the nucleoskeleton (Dittmer and Misteli, 2011) (Figure 1.1). The nuclear 
lamina in mammals mainly include two types of lamins, A-type and B-type, which form a 
filamentous meshwork connecting with the INM. The A-type Lamins including lamins A, C, 
AΔ10, C2, and AΔ50 (also known as ‘progerin’) are generated by alternative splicing of 
LMNA (Bokenkamp et al., 2011; Dittmer and Misteli, 2011) while the B-type Lamins 
including lamins B1, B2 and B3 are encoded by different genes, LMNB1 and LMNB2 
(Dittmer and Misteli, 2011; Schumacher et al., 2006). The nuclear lamina have several 
important roles such as connecting chromatin, interacting with signalling proteins and 
supporting epigenetic regulation, mechanotransduction, development, transcription, 
replication and DNA damage repair (Dechat et al., 2008; Dittmer and Misteli, 2011; Simon 
and Wilson, 2011). 
LEM protein family members have been characterized along with other INM proteins 
(Wagner and Krohne, 2007). They are defined according to the presence of a common 
structural bihelical motif named as LEM [LAP2 (lamina-associated polypeptide 2) / emerin / 
MAN1] domain (Laguri et al., 2001; Lin et al., 2000). In different experiments, the typical 
LEM domain always show strong interaction with BAF (barrier to autointegration factor) (Cai 
et al., 2001; Cai et al., 2007; Shumaker et al., 2001), an critical 10 kDa chromatin-associated 
protein identified in all metazoan (Margalit et al., 2007; Margalit et al., 2005; Zheng et al., 
2000). Therefore, LEM domain proteins are considered to be dynamically associated with 
chromatin (Shimi et al., 2004), probably regulated by BAF phosphorylation (Bengtsson and 
Wilson, 2006; Gorjanacz et al., 2007; Nichols et al., 2006) and other unknown mechanisms so 
far (Figure 1.1). 
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1.2 Nuclear envelope and human disease 
Due to the extensive cellular functions related to nucleo-cytoskeletal coupling, it is not 
surprised that mutations in LINC complex-associated proteins can result in a large number of 
human diseases (Isermann and Lammerding, 2013) (Figure 1.6).The majority of diseases are 
caused by mutations in the LMNA gene, encoding lamin A and C, collectively named 
laminopathies (Butin-Israeli et al., 2012; Worman, 2012). So far almost 400 different disease-
causing mutations in A-type lamins have been identified, emphasizing their importance to cell 
and tissue biology and human physiology. The disease can affect specific tissues (striated 
muscle, adipose tissue, or peripheral nerves) or the whole body. To date, many laminopathies 
have been found including Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy, 
limb-girdle muscular dystrophy, Charcot-Marie-Tooth, familial partial lipodystrophy or 
accelerated aging disorder Hutchinson-Gilford progeria syndrome (Schreiber and Kennedy, 
2013). Clinically, overlapping phenotypes are also identified in these laminopathies (Ellis and 
Shackleton, 2011). 
Diseases caused by mutations or gene duplications have been mapped to B-type lamins 
(Schreiber and Kennedy, 2013). Duplication of the LMNB1 gene can result in adult onset 
leukodystrophy (Brussino et al., 2010; Molloy et al., 2012; Padiath et al., 2006; Schuster et 
al., 2011), or leukoencephalopathy (Brussino et al., 2009), characterized by demyelination in 
the central nervous system. Mutations in LMNB2 cause increased sensitivity to acquired 
partial lipodystrophy, which involves a progressive loss of subcutaneous fat tissue (Gao et al., 
2012; Hegele et al., 2006). The disease cause for the wide range of nuclear envelopathies is 
still unknown.  
However, the mutations in emerin (STA or EMD gene), nesprin-1 (Syne-1) and nesprin-2 
(Syne-2) can also affect striated muscle, resulting in Emery-Dreifuss muscular dystrophy and 
dilated cardiomyopathy, indicating a LINC complex-associated disease mechanism 
(Gundersen and Worman, 2013). Apart from these muscular disease, mutations in nesprin-1 
can also cause autosomal recessive cerebellar ataxia (Gros-Louis et al., 2007) and 
arthrogryposis (Attali et al., 2009), which is identified in congenital joint contractures 
resulting from reduced fetal movements. The expression of Nesprin-4 is restricted in secretory 
epithelial cells and hair cells of the inner ear (Roux et al., 2009), while its mutations can cause 
progressive high-frequency hearing loss and the phenotype also can be detected in mice 
deficient in either nesprin-4 or SUN1 (Horn et al., 2013). Among these diseases, cardiac and 
skeletal muscles are experienced especially high levels of mechanical stress; therefore, 
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nucleo-cytoskeletal coupling and nuclear mechanics might be important for the cause of the 
disease phenotype (Isermann and Lammerding, 2013; Schreiber and Kennedy, 2013). 
 
 
 
 
Figure 1.6 LINC complex-associated proteins involved human disease (Mejat and Misteli, 2010). 
“Envelopathies” means that the disease in human is caused by the mutations of the NE associated proteins. The 
names of the diseases caused by particular mutated proteins are shown. 
 
 
1.3 Nuclear envelope and mRNA export 
As we mentioned before, the nuclear envelope plays an important role in separating the 
inclusion of the nucleus from the cytoplasm. mRNA transcription takes place in the nucleus, 
while mRNA translation into functional protein happens in the cytoplasm (Hocine et al., 
2010; Moore and Proudfoot, 2009). This spatial problem is settled by the efficient mRNA 
export from the nucleus into the cytoplasm (Natalizio and Wente, 2013).  
A crucial structure involved in the mRNA export process is the NPC present at the fusion 
point of the ONM and the INM (Capelson et al., 2010). The NPCs are embedded in the NE 
and have functions in selective material transport (Aitchison and Rout, 2012; Grossman et al., 
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2012). For small molecules, like water, sugar and ions, the NPC channel is open and free for 
crossing, however, in case of bigger molecules (5-40 nm in diameter) such as proteins, rRNA 
and messenger ribonucleoprotein (mRNP), particular receptors are required for crossing the 
NPC (Aitchison and Rout, 2012; Guttler and Gorlich, 2011).  
mRNA export is a multi-stage process in which the transcripts have to connect with the 
nucleoplasmic side of the NPC, the nuclear basket, translocate through the central channel, 
and be released from the cytoplasmic fibrils into the cytoplasm (Carmody and Wente, 2009; 
Siddiqui and Borden, 2012; Strambio-De-Castillia et al., 2010). Therefore the nuclear export 
of mRNA transcripts can be divided into three different stages: first, pre-mRNA is packaged 
into mRNP complex after corrected transcription and processing; second, the mRNP targets 
and translocates through the central channel of NPC; third, the cytoplasmic fibrils release the 
mRNP into the cytoplasm for translation (Carmody and Wente, 2009). 
 
1.3.1 mRNA transcription and processing  
Transcription is the first step of the mRNP formation. Many kinds of factors bind to the 
nascent mRNA transcript for helping transcriptional elongation. Some of the factors belong to 
heterogeneous nuclear ribonucleoproteins (hnRNPs) family. The hnRNPs are nuclear RNA-
binding proteins with a high abundance in the cell. About 30 different hnRNPs have been 
found in human, while ~10 exist in Saccharomyces cerevisiae (Dreyfuss et al., 2002). The 
hnRNP proteins have various functions and accompany the mRNA at different stages during 
mRNP export (Dreyfuss et al., 2002). The nuclear restricted hnRNPs containing nuclear-
retention signal are released from the mRNP and stay in the nucleus prior to export, while the 
shuttling hnRNPs accompany the mRNA through the NPC channel and into the cytoplasm, 
and then shuttle back to the nucleus (Carmody and Wente, 2009; Dreyfuss et al., 2002) 
(Figure 1.7). 
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Figure 1.7 The hnRNPs and other factors required during mRNP export (Dreyfuss et al., 2002). 
Multifunction hnRNPs involved in transcription, processing, packaging, export and translation are shown. These 
hnRNPs accompany the mRNA at different steps during mRNP export. EJC, exon-exon junction complex; 
NMD, nonsense-mediated mRNA decay; RNA pol II, RNA polymerase II; snRNP, small nuclear 
ribonucleoprotein; PABP, poly(A)-binding protein; m
7G, 5′ 7- methylguanosine cap. 
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1.3.2 Targeting and translocating through the NPC 
There are two major transport receptors involved in two distinct mRNA export pathways: 
NXF1 (nuclear RNA export factor 1, also known as TAP) and CRM1 (chromosome region 
maintenance 1, also known as exportin-1) (Carmody and Wente, 2009; Culjkovic-Kraljacic 
and Borden, 2013; Kohler and Hurt, 2007; Natalizio and Wente, 2013) (Figure 1.8). Based on 
the diversity of transport receptors, mRNA export can be roughly classified into two forms: 
bulk and specific export (Culjkovic-Kraljacic and Borden, 2013). Most of the constitutively 
expressed mRNAs are exported by the NXF1-dependent pathway (bulk export). There are at 
least three kinds of adaptor proteins, Aly/REF, GANP and SR (serine- and arginine-rich) 
proteins, attach NXF1 receptor and accelerate mRNA export (Culjkovic-Kraljacic and 
Borden, 2013; Wickramasinghe et al., 2010). By contrast, specialized subsets of mRNAs, 
uridine-rich small nuclear ribonucleoprotein particles (UsnRNAs), rRNAs, and signal 
recognition particle (SRP) RNA are exported by the CRM1-dependent pathway (specific 
export) (Natalizio and Wente, 2013). Like NXF1, CRM1 also has multiple adaptors involved 
in mRNA export, such as HuR, eIF4E and NXF3 (Culjkovic et al., 2006; Hutten and 
Kehlenbach, 2007; Topisirovic et al., 2009; Yang et al., 2001). 
 
1.3.3 Releasing into the cytoplasm and linking to translation 
After passing through the central channel of the NPC, mRNP is released from the cytoplasmic 
fibrils to start translation which is the last step of the export (Carmody and Wente, 2009). In 
the NXF1-dependent pathway, the mRNP cargo will be associated with the cytoplasmic fibrils 
of the NPC once it reaches the cytoplasmic face and then be released by these fibrils. 
Meanwhile, the export factors start recycling. The regulation of the process is crucial for the 
export efficiency. Nup358 (also referred to RanBP2) is one of the proteins forming the long 
fibrils at the cytoplasmic face of the NPC, providing the binding sites for NXF1 (Hutten and 
Kehlenbach, 2007; Wente and Rout, 2010). In the CRM1-dependent pathway, the release of 
the mRNP into the cytoplasm requires the help from RanGAP (Ran GTPase-activating 
protein) and RanBP1 (or RanBP2) which enable GTP to be hydrolysed by Ran. The CRM1-
cargo complex disassembles into mRNA and export factors, leaving mRNA to start 
translation and export factors to recycle (Hutten and Kehlenbach, 2007).  
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Figure 1.8 Overview of the NXF1-dependent and CRM1-dependent mRNA export pathways (Modified 
from Culjkovic-Kraljacic and Borden, 2013). The NPC-dependent mRNA export is divided into two main 
pathways: the NXF-dependent and the CRM1-dependent pathway. Based on the variety of the adaptor proteins, 
each export pathway can be subdivided into several branches. For instance, the NXF1-dependent pathway could 
be independently mediated by Aly/REF, GANP or SR proteins. Likewise, the CRM1-dependent pathway is 
categorized according to the involvement of HuR, eIF4E or NXF3 proteins. The main export factors involved in 
these pathways are shown.  
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1.4 Aims of this work 
The LINC complex is well known for functions in mechanotransduction and more and more 
reports raise the association between the LINC components and human disease, particularly in 
the pathophysiology of EDMD (Emery-Dreifuss muscular dystrophy). SUN1 and SUN2 
being crucial components of the LINC complex became our obvious candidates of 
investigation with respect to EDMD.  
The first part of my project has two major objectives: 
 To examine the influence of SUN1 mutations in primary fibroblasts from two 
EDMD patients.  
- Phenotypic characterization of the patient cells. 
 To address the molecular pathology underlying the disease. 
- Study the defects of LINC components at the protein level, including the 
localization, expression and their interactions. 
Until now, the role of SUN1 was mainly restricted to the functions in the LINC complex in 
concert with the KASH domain proteins.  
The second part of my project expands the role of SUN1 and has a third objective: 
 To reveal whether SUN1 has additional functions in mammalian cells aside from 
its role in the LINC complex.  
- Confirm the interaction of SUN1 with hnRNPs.  
- Conduct knockdown studies of SUN1 to biochemically characterize the 
importance of SUN1 in hnRNP-containing mRNA export.  
- Identify the interaction partners of SUN1 involved in mRNA export pathway. 
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2. Results 
2.1 Contribution of SUN1 mutations to the pathomechanism in muscular 
dystrophies 
2.1.1 Patient information 
We used primary ﬁbroblasts from two patients (Patients 1 and 2, passage 11) suffering from a 
muscular dystrophy compatible with the clinical phenotype of Emery-Dreifuss muscular 
dystrophy (EDMD). Patient 1, male, had a mutation in the X-linked emerin gene EMD (STA) 
(hemizygous p.L84Pfs*6 in NCBI CAG38773) and harbored an additional heterozygous 
mutation in the SUN1 gene leading to an amino acid exchange in the amino terminus at 
position 203 (p.A203V in NCBI O94901). SUN1 p.A203V was found in a reference 
population at a very low frequency of 0.00092 (SUN1 p.A203Vrs144929525; 4/2180; 
1000GENOMES:phase_1_ALL). The heterozygous SUN1 mutation alone is not disease 
causing. As seen in the pedigree of patient 1, family members II-2 and II-3 are heterozygous 
for the SUN1 p.A203V mutation only and phenotypically healthy (Figure 2.1). But in 
combination with the EMD mutation p.L84Pfs*6, a more severe EDMD phenotype is 
observed (Hoeltzenbein et al., 1999). 
Patient 2, a female patient suffering from an unclassified muscular dystrophy (see Materials 
and Methods) harbored a heterozygous mutation in the LAP2α gene TMPO (p.P426L in 
NCBI NP_003267) and a heterozygous mutation in the C-terminus of SUN1 (p.A614V in 
09491, corresponds to p.A718V in 09491-9 (NCBI)). The SUN1 mutation was found in a 
reference population at a very low frequency of 0.00046 (SUN1 p.A614V rs114701323; 
1/2183; 1000GENOMES:phase_1_ALL). 
 
 
 
Figure 2.1 Segregation of the 
mutations EMD p.L84Pfs*6 and 
SUN1 (p.A203V) in the pedigree of 
patient 1 (II-6). Females are 
represented as circles and males as 
squares. Affected males are black 
filled squares. Circles with a central 
dot symbolize female carriers. Cross 
slatched figures represent deceased 
individuals.
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2.1.2 The patient cells have defects in cell proliferation and cell size 
The contributions of the heterozygous mutations in SUN1 to the disease are not known. 
Therefore we carried out investigations on the cellular level to probe for alterations that are 
associated with diseases caused by mutations in components of the NE. To evaluate the 
proliferation potential of the EDMD patient cells, 1x10
5
 patient and wild-type cells were 
seeded and counted every 48 h for a period of 6 days. The cells from patient P1 exhibited a 
remarkably reduced growth compared to the wild-type. In contrast, fibroblasts from patient P2 
showed increased growth compared to wild-type (Figure 2.2A). The observed alterations may 
be caused by changes in the cell cycle phases. Therefore we checked the cell cycle 
distribution of exponentially growing control fibroblasts and fibroblasts from patients by flow 
cytometry and observed for P1 cells a significantly lower number of cells in M phase whereas 
wild-type and P2 cells did not significantly differ from each other (Figure 2.2B). 
Determination of the cell sizes revealed that P1 cells had an increased cell size compared to 
wild-type and P2 cells which were similar in size to wild type (Figure 2.2C).  
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Figure 2.2 Defects in cell proliferation, cell cycle and cell size in EDMD patient cells. A: Cell proliferation of 
the wild-type and patient fibroblasts. 1x10
5
 cells of each cell type were seeded. Cell numbers were determined 
every 48 h for a period of 6 days. B: Cell cycle analysis of wild-type and patient fibroblasts was done by flow 
cytometry. 5x10
5
 cells each were used. C: Cell size of patient and wild-type fibroblasts. Bar: 100 μm. The values 
represent the mean ±SD.  
 
2.1.3 The patient cells show differences in centrosome distance and senescence 
The centrosome plays a key role in cellular architecture by determining the position of several 
associated organelles, including the nucleus. Previous work indicated that nuclear envelope 
proteins like the LINC-proteins and emerin participate in centrosome-nucleus juxtaposition 
and mediate shuttling of nuclear and centrosomal proteins between these organelles 
(Salpingidou et al., 2007; Schneider et al., 2011; Zhang et al., 2009). Therefore we 
investigated the localization of the centrosome relative to the nucleus using antibodies against 
pericentrin (Figure 2.3A). The nucleus-centrosome distance was measured for 200 cells for 
each cell line using Leica LAS AF Lite software. In wild-type cells the mean distance of the 
nucleus to the centrosome was about 2.7 µm, for P2 cells we observed a decreased 
centrosome distance (~1.9 µm), and for P1 cells the distance was significantly increased (~3.8 
µm) (Figure 2.3A). 
An increased senescence has been reported for cells harbouring defects in components of the 
nuclear envelope (Le Dour et al., 2011). We queried how nuclear envelope mutations affected 
senescence and examined senescence-associated β-galactosidase (SA-β-Gal) in control and 
C 
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patient cells (Figure 2.3B). In wild-type cells, less than 10 % of the cells were β-galactosidase 
positive, in P2 cells we observed staining in ~30 % and in P1 cells this number increased to 
50 % (Figure 2.3B). 
 
 
 
 
 
Figure 2.3 Alterations in centrosome distance and senescence. A: Nucleus-centrosome distance is altered in 
patient cells. Immunofluorescence analysis of wild-type and EDMD patient cells was performed by using 
Pericentrin antibodies to localize the centrosome and Lamin A/C antibodies to label the NE. Bar, 10 μm. 
Evaluation is shown in the bar graph below. B: Visualization (upper panel) and quantification (lower panel) of 
senescence associated β-galactosidase show differences between wild-type and patient cells. Standard deviations 
are from three independent assays counting 400-500 cells in each experiment. The P values are indicated. Bar, 
100 µm. 
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2.1.4 Heat shock induces severe nuclear shape alterations in patient cells 
Nuclei from laminopathy cells have an increased sensitivity to heat stress and deform upon a 
heat shock (Vigouroux et al., 2001). To evaluate the resistance of the NE to damage induced 
by heat stress, control and patient fibroblasts were subjected to heat shock treatment for 30 
min at 45
0
C. Following the treatment, the cells were immediately fixed and stained for Lamin 
A/C to assess nuclear shape changes. Normally nuclei have an ellipsoid shape and Lamin A/C 
is homogenously distributed along the NE. In wild-type cells Lamin A/C distribution was not 
dramatically altered upon heat stress whereas the number of deformed nuclei was increased. 
Patient fibroblasts showed an altered nuclear shape already in untreated cells. After heat 
treatment the number of cells with nuclear abnormalities increased further, however the 
difference to wild-type fibroblasts was not statistically significant. The NE of the nuclei was 
deformed and folds and pleats occurred (Figure 2.4A, B). These results suggest an alteration 
in the nuclear protein network that resulted in hypersensitivity to heat stress induced 
deformation. We also determined whether heat shock affected the centrosome positioning and 
stained for the centrosome marker pericentrin. We found that the nucleosome-centrosome 
distance was not altered in wild-type cells and slightly but not significantly increased in 
patient cells after heat shock (Figure 2.4C).  
 
 
 
A 
Results 
 20 
 
         
       
Figure 2.4 Heat shock induces severe nuclear shape alterations in EDMD fibroblasts. A: Wild-type and 
patient cells were subjected to heat shock treatment at 45
0
C for 30 min and fixed immediately in ice cold 
methanol and immunolabeled for Lamin A/C. Nuclei of untreated cells (left column) and heat stressed cells 
nuclei (middle and right columns) as indicated on top are shown. Stars point out alterations. Bar, 10 μm. B: The 
numbers of deformed and disorganized nuclei prior to and after heat shock were determined. Between 300 to 500 
cells were analyzed. C: Analysis of the nucleus centrosome distance after heat shock. The cells were stained for 
Lamin A/C and Pericentrin as centrosomal marker. 200 cells each were analyzed. The values represent the mean 
±SD. 
 
2.1.5 Cell migration is altered in patient cells in an in vitro wound healing assay 
Earlier studies have demonstrated that mutations in key NE proteins can result in slower 
migration of fibroblasts (Houben et al., 2009; Lee et al., 2007; Luke et al., 2008). To 
investigate whether the mutations studied in this report also affect cell migration, wound 
healing assays were performed. We analysed the velocity of gap closure and determined the 
speed of single cells. We followed the gap closure over 20 h taking images every 15 min. 
After 15 h the P1 cells had migrated into the open area and nearly completely closed the gap. 
In case of wild-type and P2 cells the open area was wider (Figure 2.5A). After 20 h wild-type 
cells had closed the gap whereas gap closure was still not achieved after 20 h in case of P2 
cells. Quantification of the speed with which individual cells moved supported this notion 
revealing a faster migration for P1 cells (0.384±0.05 µm/min). Wild-type and P2 cells 
exhibited a similar speed and migrated at 0.266±0.05 µm/min and 0.282±0.004 µm/min, 
respectively (Figure 2.5B).  
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Figure 2.5 In vitro wound healing is altered in patient cells. A: Gap closure of wild-type and patient 
fibroblasts. Pictures from the 0 and 15 hour time points are shown. Cells were seeded at a density of 4 x 10
4
 cells 
on each side of a culture insert. Inserts were removed to create a 500 μm gap between each side. The cell 
migration into the gap was followed over a period of 20 h under an inverted microscope with a live cell imaging 
system. B: The velocity of single cell migration. For analysis of the single cell motility, 100-130 cells were 
tracked using the manual tracking software component of the Image J program. 
 
2.1.6 Transcript and protein levels but not localization of LINC components and 
binding partners are altered in patient cells 
Based on the finding that the patients have mutations in SUN1 and other nuclear envelope 
proteins, we investigated the localization of LINC components and their binding partners by 
immunofluorescence. In particular we studied the distribution of Lamin A/C, Lamin B1, 
SUN1 and SUN2, Nesprin-1 and Nesprin-2, LAP2 and Emerin. All proteins were present at 
the NE (Figure 2.6A). The Nesprin-1 antibodies in addition stained filamentous structures in 
the cytoplasm which are presumably actin filaments (Padmakumar et al., 2004). In P1 cells 
Emerin was absent as expected (Figure 2.6A). A subsequent analysis of the protein levels 
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showed comparable expression for Lamin A/C in all cells, whereas Lamin B1 and Nesprin-2 
amounts were significantly reduced in P1. For SUN1 and LAP2 we observed a reduction in 
both patient cells. SUN2 amounts were significantly higher in P2 cells (Figure 2.6B). 
Surprisingly, at the transcript level we observed an up-regulation in case of Lamin B1 and 
LAP2 for both patient cells and in case of Nesprin-2 for P1 cells as determined by qRT-PCR. 
No significant alterations were seen for SUN1 and SUN2 (Figure 2.6C; Table 1).  
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Figure 2.6 Localization, expression and transcript levels of LINC components and binding partners. A: 
Immunofluorescence analysis of LINC components and binding partners using appropriate antibodies. Bar, 10 
µm. B: Western blot analysis for several NE proteins. Whole cell lysates were separated by SDS-PAGE (12% 
acrylamide). For detection of Nesprin-1 and -2, 3-15% acrylamide gradient gels were used. For loading control 
GPADH levels were determined by GAPDH antibodies. C: qRT-PCR analysis for detection of transcript levels. 
*p < 0.05, **p < 0.01, ***p < 0.001.   
 
2.1.7 Analysis of SUN1 mutations 
The Emery-Dreifuss muscular dystrophy P1 fibroblasts have a mutation p.A203V in the N-
terminus of SUN1, and P2 fibroblasts have a SUN1 mutation p.A614V in the C-terminus. 
These mutations we considered possibly pathogenic, because they affect amino acids that are 
well conserved among SUN proteins from other species, in particular A203 is highly 
conserved (Figure 2.7A). In order to identify whether the SUN1 mutations are responsible for 
any of the observed defects of the patient cells we introduced these mutations into wild-type 
GFP-tagged SUN1 by site-directed mutagenesis and expressed the corresponding proteins in 
wild-type fibroblasts. 
We found that GFP-SUN1, GFP-SUN1A203V and GFP-SUN1A614V were expressed at 
comparable levels and were present at the NE in the transfected cells. Next we focused on the 
expression levels of Lamin B1, SUN1, SUN2, LAP2 and Nesprin-2 by western blotting. We 
observed no significant differences between cells expressing the wild-type or mutant versions 
of SUN1 which suggested that the SUN1 mutations do not affect the amounts of the proteins 
(Figure 2.7B). Also, the localization pattern of these NE components appeared unperturbed 
with the exception of emerin and LAP2 (Figure 2.7C-G). In untransfected cells Emerin and 
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LAP2 antibodies labelled the NE. Ectopic expression of wild-type SUN1 and the mutant 
proteins led to a decrease of Emerin at the NE and a faint labelling was seen. In addition, 
Emerin positive aggregate like structures were observed at the NE. Occasionally these 
aggregates were also positive for GFP. Moreover, LAP2 positive dot like structures were also 
present at the NE with a faint labelling in cells expressing wild-type SUN1 and the mutant 
proteins (Figure 2.7E, F). We also noticed a down regulation of SUN2 in GFP-SUN1 
overexpressing cells (Figure 2.7G). This result contradicts our findings obtained with patient 
cells. However, here we have overexpressed SUN1 which is not the case in the patient cell, 
further in the patient cell the situation is more complex as there is the additional heterozygous 
mutation in the LAP2α gene.  
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2.1.8 The mutations in SUN1 affect the interactions with Emerin and Lamin A/C  
Although the NE components tested with the exception of Emerin and LAP2 had an 
unperturbed localization at the NE and unaltered amounts it might well be that the interactions 
between them were altered. We therefore performed co-immunoprecipitation and pulldown 
experiments and analyzed the interaction between the GFP-tagged SUN proteins and Emerin 
in human fibroblasts. We found that GFP-SUN1 and both GFP-SUN1A203V and GFP-
SUN1A614V could co-immunoprecipitate Emerin (Figure 2.8A). A more quantitative 
analysis using densitometry revealed that the SUN1 mutant proteins precipitated less Emerin 
compared to WT SUN1, however, the difference was not significant (Figure 2.8A). 
SUN proteins directly bind to Lamin although this interaction is not required for SUN1 
localization at the NE. The interaction site in Lamin A was located in the tail region, in SUN1 
an amino terminal region encompassing residues 1 to 138 was identified as interaction site 
(Haque et al., 2010; Simon and Wilson, 2013). We used GST-CT-Lamin A/C for pulldown 
 
Figure 2.7 A: SUN1 mutations analysis and site-
directed mutagenesis. Multiple alignment of amino 
acids for part of SUN1 shows conservation of 
Alanine residues at position 203 and position 614 
for p.Ala203Val and p.Ala614Val. NCBI accession 
numbers are: HUMAN, O94901; MOUSE, 
Q9D666; Nomascus leucogenys, XM_003278674.2; 
Orcinus orca, XM_004269058.1; Ovis aries, 
XM_004021337.1; Taeniopygia guttata, 
XM_002191424.2; Tursiops truncatus, 
XM_004316169.1. B: Wild-type fibroblasts were 
transfected with GFP-SUN1, GFP-SUN1A203V 
and GFP-SUN1A614V plasmids and the expression 
of Lamin B1, SUN2, LAP2 and Nesprin-2 was 
checked by western blot analysis. C-G: Wild-type 
fibroblasts were transfected with GFP-SUN1, GFP-
SUN1A203V and GFP-SUN1A614V plasmids and 
the expression and localization of Lamin A/C (C), 
Lamin B1(D), Emerin (E), LAP2 (F) and SUN2 (G) 
were studied by immunofluorescence. Bar: 5 µm. 
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assays to check the interaction with SUN1 in wild-type and patient fibroblasts. In these 
experiments SUN1 wild-type was efficiently precipitated whereas both SUN1 mutant proteins 
were present in the precipitate in reduced amounts (Figure 2.8B). GST alone did not 
precipitate the proteins. The results suggested that the SUN1 mutations can affect the binding 
ability to Lamin A/C.  
        
 
 
 
        
 
Figure 2.8 Interaction of SUN1 with Emerin and Lamin A/C. A: Co-immunoprecipitation of Emerin with 
GFP-SUN1, GFP-SUN1A203V and GFP-SUN1A614V. For immunoprecipitation polyclonal GFP antibodies 
were used. The immunoprecipitate was probed with Emerin and GFP specific antibodies (upper panel). The 
binding was quantified by scanning densitometry (lower panel). The P values are indicated. B: Lamin A/C 
interaction of mutant SUN1 in patient fibroblasts. The top panel shows a schematic of Lamin A/C and CT-Lamin 
A/C (residues 128-572) used as GST fusion protein (Libotte et al., 2005). For pulldown assays, GST and GST-
CT-Lamin A/C were used to check the interaction with SUN1 in wild-type and patient fibroblasts (middle 
panel). The proteins were separated by SDS-PAGE (12% acrylamide). Scanning densitometry was used to 
determine the binding ability (lower panel). 
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2.2 Inner nuclear envelope protein SUN1 plays a prominent role in 
mammalian mRNA export 
2.2.1 SUN1 and SUN2 interact with hnRNP F/H and hnRNP K/J 
In a previous study, in order to understand the role of SUN proteins, we screened for SUN 
interacting proteins by applying pulldown experiment and LC-MS analysis (Taranum et al., 
2012). Many proteins taking part in gene regulatory processes were found. The hnRNPs, like 
hnRNP F/H and hnRNP K/J, are interesting candidates involved in RNA processing. To 
confirm the interaction between SUN1/2 and hnRNPs, we performed co-immunoprecipitation 
(Co-IP) and pulldown experiments. For Co-IP study, wild-type fibroblasts were transfected 
with GFP, GFP-SUN1 or GFP-SUN2 and both the GFP fusion proteins and their partners 
were immunoprecipitated by GFP-Trap beads. For pulldown assay, GST tagged the N-termini 
of SUN1 (residues 1-239) and SUN2 (residues 1-138) (Figure 2.9A) were directly incubated 
with the cell lysates and GST alone was used as negative control. All the samples were 
subjected to western blot analysis and probed with GFP monoclonal antibodies. Strong 
signals of hnRNP F/H and K/J were detected in both experiments confirming that hnRNP F/H 
and hnRNP K/J were associated with SUN1 and SUN2 (Figure 2.9B). We further examined 
the localization of the endogenous proteins by immunofluorescence. Consistent with previous 
studies, hnRNP F/H and hnRNP K/J were shown mainly in the nucleus and colocalized with 
both SUN1 and SUN2 along the inner nuclear envelope (Figure 2.9C).  
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Figure 2.9 Interaction and colocalization of SUN1/2 and hnRNPs. A: Schematic of the full length and the N-
termini of SUN1 and SUN2 used in this thesis. Transmembrane, coiled-coil and SUN domain are shown. B: 
Western blots analysis of Co-IP and pulldown between SUN1/2 and hnRNPs. For Co-IP, lysates from human 
fibroblasts expressing GFP alone, GFP-SUN1 or GFP-SUN2 were immunoprecipitated by using GFP-Trap 
beads and detected by GFP monoclonal antibodies. For pulldown experiment, GST, GST-SUN1-NT and GST-
SUN2-NT were used and visualized by Ponceau S staining. The proteins were separated by SDS-PAGE (12% 
acrylamide) and the interactions were detected by hnRNP F/H and hnRNP K/J antibodies. C: Colocalization of 
endogenous SUN1/2 and hnRNP F/H or hnRNP K/J. HeLa cells were stained with required antibodies and 
analyzed by immunofluorescence. Bar: 5 µm. 
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2.2.2 hnRNP F/H and hnRNP K accumulate in the nucleus by SUN1 depletion   
The hnRNPs are RNA-binding proteins with a diverse function in gene regulation including 
nascent transcript packaging, alternative splicing, nucleocytoplasmic transport and 
translational regulation (Dreyfuss et al., 2002; Han et al., 2010). Considering that SUN1 and 
SUN2 are INM proteins, they might play a crucial role in hnRNP-associated 
nucleocytoplasmic transport. In order to verify our hypothesis, we performed small interfering 
RNA (siRNA)-mediated knockdown studies of SUN1. Immunofluorescence and western blot 
analysis confirmed the efficient knockdown of SUN1 in HeLa cells (Figure 2.10A, B). 
Immunofluorescence analysis by confocal microscopy of HeLa cells showed strong nuclear 
envelope staining for SUN1 in control siRNA cells and very weak staining of the nuclear 
interior in SUN1 siRNA cells (Figures 2.10A). Western blot analysis showed that SUN1 was 
absent from HeLa lysates after siRNA depletion (Figure 2.10B). To test whether depletion of 
SUN1 influences the distribution of hnRNPs, we performed subcellular fractionation in 
control and SUN1 knockdown cells (Figure 2.10C). SUN1 was only observed in the whole 
cell lysate and the nuclear fraction of control cells, and was not detectable in SUN1 
knockdown cells. Lamin B1 and GAPDH were used as nuclear and cytosolic marker, 
respectively. Interestingly, based on the same level of Lamin B1 and GAPDH, both hnRNP 
F/H and K appeared decreased in the cytosolic fraction of SUN1 knockdown cells and 
increased in the nuclear fraction compared to control knockdown cells (Figure 2.10C). 
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Figure 2.10 SUN1 depletion results in nuclear accumulation of hnRNPs. A:  Immunofluorescence analysis 
with SUN1 antibodies of HeLa cells showed that SUN1 is localized at the NE in control cells and abolished in 
SUN1 siRNA cells. Nuclei are indicated by DAPI staining. Bar: 10µm. B: Western blot analysis of SUN1 
expression level in control and SUN1 siRNA cells. GAPDH was used as loading control. C: Separation of 
nuclear and cytoplasmic proteins by subcellular fractionation in control and SUN1 knockdown cells. Lamin B1 
and GAPDH were used as nuclear and cytosolic markers, respectively.  
 
2.2.3 RNA fluorescence in situ hybridization (FISH) reveals nuclear accumulation 
of poly(A)+RNA in SUN1 absent cells 
The shuttling hnRNP proteins are exported along with the mRNA to the cytoplasm during 
mRNA export and have functions in mRNA localization, stability, export, and/or translational 
regulation in the cytoplasm (Dreyfuss et al., 2002). One such shuttling hnRNP which we 
found to have interaction with SUN1 and SUN2 is hnRNP K, having a key role in 
translational regulation (Collier et al., 1998; Habelhah et al., 2001; Ostareck et al., 2001; 
Ostareck et al., 1997).  
To investigate whether SUN1 plays a role in mammalian mRNA export, we examined the 
cellular distribution of poly(A)+RNA in control and SUN1 siRNA cells via RNA 
fluorescence in situ hybridization (FISH) with an oligo (dT) probe. In control cells, most 
poly(A)+RNA was cytoplasmic, except for a few discrete foci in the nucleus (Figure 2.11). In 
contrast, the SUN1 siRNA cells showed strong nuclear accumulation of poly(A)+RNA 
(Figure 2.11). Further, rescue of the mRNA export defect was performed by expressing a GFP 
tagged siRNA-resistant (R) SUN1 cDNA (GFP-SUN1
R
) under siRNA treatment condition. 
We found that the expression of GFP-SUN1
R
 with SUN1 siRNA partially rescued the mRNA 
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export defect confirming that the SUN1 knockdown phenotype was not due to off-target 
effects (Figure 2.11).  
 
Figure 2.11 SUN1 depletion results in nuclear accumulation of poly(A)+RNA. RNA FISH showed 
poly(A)+RNA accumulation in the nucleus of SUN1-depleted cells after 72 h of siRNA transfection (upper two 
panels). For rescue experiment, HeLa cells were transfected with a GFP-SUN1
R
 expression vector and processed 
for poly(A)+RNA detection by FISH after 24 h and 72 h siRNA treatment, respectively (last panel). Bar: 10µm.  
 
2.2.4 SUN1 functions in mRNA export independent of the CRM1-dependent 
pathway 
As we introduced before, mRNA export can be roughly divided into two forms: bulk and 
specific export according to the different export receptors (Culjkovic-Kraljacic and Borden, 
2013). Most of the constitutively expressed mRNAs are exported by the NXF1-dependent 
pathway (bulk export), Whereas specialized subsets of mRNAs, UsnRNAs, rRNAs, and SRP 
RNA are exported by the CRM1-dependent pathway (specific export) (Natalizio and Wente, 
2013). Additionally, Leptomycin B (LMB) is a direct inhibitor of CRM1 and can directly 
block the CRM1-dependent pathway (Kudo et al., 1998).  
SUN1 depletion resulting in nuclear accumulation of poly(A)+RNA indicates that SUN1 is 
involved in mRNA export. To further find out which mRNA export pathway requires SUN1, 
we compared the distribution of poly(A)+RNA in both LMB untreated and treated cells under 
siRNA condition (Figure 2.12A). For each trial, the nuclear/cytoplasmic (N/C) ratio of the 
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poly(A)+RNA distribution was determined by measuring the fluorescence intensity. Without 
LMB treatment, the N/C ratios of most control siRNA cells are centered at the range of [0.9-
1.3) with a mean value of ∼1.15. In contrast, the N/C ratios of most SUN1 siRNA cells are 
centered at the range of [1.3-1.7) with a mean value of ∼1.63 (Figure 2.12B, C). The shift in 
the range and the increase of the mean N/C ratio reflect higher nuclear accumulation of 
poly(A)+RNA upon SUN1 depletion. After treatment with 7 ng/ml of LMB, the N/C ratio 
ranges of both control and SUN1 siRNA cells were significantly shifted to [1.3-1.7) and [1.7-
2.1) with an increased mean value up to ~1.56 and ~1.84, respectively (Figure 2.12B,C). For 
control siRNA, the remarkable increase of the N/C ratio after LMB treatment revealed that the 
drug treatment worked under our experimental conditions. Strikingly, for SUN1 siRNA, the 
shift of the N/C ratio range and the increase in the mean value indicate that LMB treatment 
can cause additional nuclear accumulation of poly(A)+RNA above that caused by SUN1 
depletion suggesting that SUN1 plays a role in mRNA export independent of the CRM1-
dependent pathway. 
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Figure 2.12 Comparision of the nuclear accumulation of poly(A)+RNA caused by SUN1 depletion and 
LMB treatment. A: RNA FISH showed the distribution of poly(A)+RNA in both LMB untreated and treated 
cells under siRNA condition. The treatment was performed by adding 7ng/ml of LMB for 2 h after 72 h siRNA 
transfection. Bar: 10µm. B: The nuclear/cytoplasmic (N/C) ratio of the poly(A)+RNA distribution was 
determined by measuring fluorescence intensity, and the percentages of cells in each N/C ratio intensity range 
were shown. For each condition ~500 cells were analysed. C: The mean nuclear/cytoplasmic (N/C) ratio of 
LMB untreated and treated cells under siRNA condition. 
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2.2.5 SUN1 associates with nuclear mRNP through a direct interaction with 
NXF1, a general mRNA export factor in mammals 
Based on our results we assume that SUN1 might be involved in the NXF1-dependent mRNA 
export pathway (bulk export). After transcription and processing, the formation of the mRNP 
complex is the first step of mRNA export in eukaryotic cells (Carmody and Wente, 2009). To 
test whether SUN1 is associated with mRNP, we harvested the nuclear poly(A)+RNPs from 
mammalian nuclei with Dynabeads
®
 Oligo (dT)25. Endogenous SUN1 specifically copurified 
with the poly(A) fraction as did NXF1 (Figure 2.13A). Moreover, SUN2, hnRNP K and 
hnRNP H were also observed in the poly(A) fraction, but not hnRNP F (Figure 2.13A). These 
results indicate that SUN1 associates with NXF1-containing nuclear mRNP, either directly or 
indirectly through other proteins. 
NXF1, also known as TAP, is a general metazoan mRNA export factor to transport mRNP 
through the NPC (Gruter et al., 1998; Stutz and Izaurralde, 2003). In order to find out how 
SUN1 associates with mRNP and functions in the NXF1-dependent mRNA export pathway, 
we performed several studies. Western blot analysis showed that NXF1 was down regulated 
when SUN1 is absent from HeLa cell lysates after SUN1 depletion compared to control 
siRNA. GAPDH was used as a loading control (Figure 2.13B). Moreover, endogenous NXF1 
was pulled down from HeLa cell lysates by both GST tagged N-terminal SUN1 and SUN2 
(Figure 2.9A and 2.13C). Consistently, endogenous SUN1 was precipitated by GST tagged 
full length NXF1 as well (Figure 2.13D). GST was used as negative control. A direct 
interaction study between NXF1 and GST-SUN1-NT was performed by pulldown of 
thrombin cleaved purified NXF1. NXF1 was detected by NXF1 antibodies in the GST-SUN1-
NT precipitate (Figure 2.13E). These results indicate that SUN1 interacts directly with NXF1 
in vitro and the N-termini of SUN1 and SUN2 are responsible for the binding. Further, 
immunofluorescence studies showed that NXF1 uniformly localized in the nucleus of GFP- 
and GFP-SUN1-overexpressing cells (Figure 2.13F). GFP-SUN1 localized along the nuclear 
envelope as previously reported (Li et al., 2014). However, most strikingly, overexpressed 
GFP-SUN1-NT was not able to localize at the nuclear envelope; instead, it formed aggregate-
like structure both within and outside the nucleus (Figure 2.13F). Additionally, strong staining 
of NXF1 was observed along these GFP-SUN1-NT aggregate-like structures and only faint 
staining was seen in the nucleus as compared to untransfected cells (Figure 2.13F). These 
results indicate that SUN1 presumably associates with mRNP cargo through a direct 
interaction with NXF1 in the nucleus, and the N-terminus of SUN1 (1-239) is responsible for 
this connection.   
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Figure 2.13 SUN1 associates with mRNP and mRNA export component NXF1. A: SUN1 interacts with 
nuclear poly(A)+RNPs. Nuclear poly(A)+RNA purified from soluble nuclear extract of HeLa cells was analysed 
by western blotting for associated proteins. B: Western blot analysis showed the down regulation of NXF1 in 
SUN1 depleted HeLa cell lysates. GAPDH was used as loading control. The expression level was quantified by 
scanning densitometry (right panel). C: The N-termini of SUN1 and SUN2 interact with NXF1. Endogenous 
NXF1 was pulled down from HeLa cell lysates by GST tagged N-termini of SUN1 and SUN2. D: NXF1 
interacts with SUN1. Endogenous SUN1 was precipitated by GST tagged full length NXF1. E: The N-terminus 
of SUN1 directly interacts with NXF1 released from the GST part after thrombin cleavage. F: 
Immunofluorescence showed the altered localization of NXF1 in GFP- , GFP-SUN1-NT- and GFP-SUN1-
overexpressing cells. Bar: 10 µm. For all pulldown experiments, proteins were separated by SDS-PAGE (12% 
acrylamide) and the GST fusion proteins were visualized by Ponceau S staining. GST was used as negative 
control. 
 
2.2.6 SUN1 associates with the NPC through a direct interaction with Nup153, a 
nuclear FG nucleoporin at the NPC basket involved in mRNA export 
Our observation that SUN1 interacts directly with NXF1, that it is present at the nuclear 
envelope, suggests a role for SUN1 in mammalian mRNA export whereby SUN1 recruits 
NXF1-containing mRNP onto the nuclear envelope and hands it over to the NPC. One 
prediction of this hypothesis is that SUN1 depletion should reduce the association of NXF1 
and NPC. However, SUN1 depletion reduced the amount of NXF1, showed in figure 2.13B.  
Furthermore, previous reports highlighting the association of SUN1 and NPC revealed that 
SUN1 is important for NPC assembly in early steps of interphase and for its distribution 
across the nuclear surface (Chang et al., 2015; Liu et al., 2007; Talamas and Hetzer, 2011). To 
further confirm the association between SUN1 and NPC, we performed pulldown experiment. 
Western blot analysis showed that endogenous Nup62, Nup153 and a faint band of Nup214 
were observed in GST-SUN1-NT precipitates by using mAb414 antibodies (Figure 2.14A). 
Surprisingly, these nucleoporins were not precipitated by GST-SUN2-NT. However, this is 
consistent with the previous results that SUN1 but not SUN2 colocalizes with Nup153 and 
NPC (Liu et al., 2007; Lu et al., 2008). These results indicate that SUN1 associates with the 
NPC via either direct or indirect interaction with a subset of nucleoporins, such as Nup62, 
Nup153 and Nup214.  
To date, apart from vertebrate pore proteins Nup98, Nup133, Nup160, Tpr, and 
CAN/Nup214, Nup153 has been involved in the export of mRNA (Dimaano and Ullman, 
2004; Kohler and Hurt, 2007). Moreover, compared to Nup62 and Nup214, GST tagged 
SUN1 N-terminus showed a preference for Nup153, given that there was much lower amount 
of Nup153 present in the input lysates (Figure 2.14A). Thus, we extended our interaction 
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studies to SUN1 and Nup153. According to the domain structure of Nup153, we used a series 
of plasmids which coded for the N-terminus, Zinc finger and C-terminus of Nup153 for 
pulldown experiment (Figure 2.14B). Endogenous SUN1 was precipitated by all GST fusion 
proteins which contain either N-terminal or C-terminal sequences, but not by the Zinc finger 
alone (Figure 2.14C). This result indicates that Nup153 interacts with SUN1, and that both the 
N- and C-terminus are important for this binding. Further, a direct interaction study between 
Nup153 and GST-SUN1-NT was performed by pulldown using PreScission protease cleaved 
purified Nup153-Zn+C fragment. A strong signal of Nup153-Zn+C was detected by Nup153 
antibodies in the GST-SUN1-NT precipitate (Figure 2.14D). GST alone was used as negative 
control. Therefore, SUN1 associates with the NPC through Nup153, which is a nuclear FG 
nucleoporin at the NPC basket and plays an important role in mRNA export.  
Additionally, it was reported that Nup153 is highly mobile and present at different parts of the 
pore as well as in the interior of the nucleus (Daigle et al., 2001; Griffis et al., 2004). This 
strongly supports our hypothesis that SUN1 recruits NXF1-containing mRNP onto the NE 
and hands it over to the NPC.  
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Figure 2.14 SUN1 interactions with Nup153, a nuclear FG nucleoporin involved in mRNA export. A: The 
N-ternimus of SUN1 interacts with Nup62, Nup153 and Nup214. Western blot analysis showed that endogenous 
Nup62, Nup153 and a faint band of Nup214 were present in the precipitate of GST-SUN1-NT but not GST-
SUN2-NT by using mAb414 antibodies. B: The predicted domain structure and a schematic of several Nup153 
polypeptides which contain N-terminus, Zinc finger and/or C-terminus. C: Both the N- and C-terminus of 
Nup153 interact with SUN1. The pulldown experiment showed that endogenous SUN1 was precipitated by all 
GST fusion proteins which contain either N-terminus or C-terminus of Nup153, but not by Zinc finger sequences 
alone. D: The N-terminus of SUN1 directly interacts with Nup153-Zn+C fragment which was obtained by 
PreScission protease cleavage and detected by Nup153 antibodies. In all the pulldown experiments, proteins 
were separated by SDS-PAGE (12% acrylamide) and the GST fusion proteins were visualized by Ponceau S 
staining. GST was used as negative control. 
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3. Discussion 
3.1 Contribution of SUN1 mutations to the pathomechanism in muscular 
dystrophies 
The analysis of the patient cells revealed defects in several cellular properties that have been 
also associated with mutations in other NE components. This is explained by the complex 
nature of the NE and the many interactions its components undergo. We compared our 
observations with data available in the literature and found that in both cases most of the 
alterations, which we observed can be linked to laminopathic mutations to various degrees 
(Table 1). In regard to the wound healing experiment and single cell motility P1 cells 
exhibited a unique behavior and showed a faster gap closure and increased cell motility. By 
contrast, Lamin A/C and Nesprin-2 deficient cells have decreased wound closure and single 
cell motility (Hale et al., 2008; Rashmi et al., 2012). Alterations in cell cycle progression, 
which is discussed as one of the disease causing mechanisms were seen in laminopathies and 
were associated with loss of SUN1 and SUN2 as well (Lei et al., 2012; Pratt et al., 2011). 
SUN proteins are central components of the LINC complex, which connects the nucleus to the 
cytosol through interactions with cytoskeletal elements such as F-actin and intermediate 
filaments. It is a major mediator of cellular mechanosensing and an important element of the 
physical pathways that transduce mechanical cues to the nucleus. Based on their central role 
they are also potential candidates in laminopathies although no mutations have been directly 
linked to this group of diseases. All SUN mutations that have been described so far were 
exclusively reported for different cancer cells [Ensembl database: www.ensembl.org; (Shan et 
al., 2013)]. Recent findings indicated that down regulation of SUN1 in Lmna deficient mice 
ameliorated the disease phenotype (Chen et al., 2012). 
SUN proteins exist as oligomers; moreover, SUN1 and SUN2 can interact with each other and 
form heterooligomers (Lu et al., 2008; Xiong et al., 2008). Structural analysis of the KASH 
SUN complex has revealed the molecular details of the interaction between the SUN domain 
of SUN2 and the C-terminal sequence of Nesprin-2 (Sosa et al., 2012; Wang et al., 2012; 
Zhou et al., 2012). The SUN domain forms a trimer and binds to three Nesprin molecules. 
The complex is stabilized by an interchain disulphide bond between a conserved cysteine in 
the KASH domain and a cysteine in the SUN domain. The coiled coil regions of SUN form a 
triple helix which is responsible for the trimer formation. The mutation A614V is not present 
in the structure solved but precedes it by 2 amino acids. The impact of the mutation on 
formation of the triple helix and its stability is therefore not clear. However, in previous work 
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we have shown that sequences preceding the SUN domain interact with the KASH domain of 
Nesprins as well and an effect of this mutation on LINC complex formation is likely 
(Padmakumar et al., 2005). In fact, upon ectopic expression of the mutant protein in wild-type 
fibroblasts the interactions at the NE with Emerin are disturbed and both patient fibroblasts 
exhibited reduced interaction with Lamin A/C (Tables 1-2). The upregulation of SUN2 in the 
P2 patient cells may ameliorate some of the laminopathic characteristics, which are less 
severe compared to the P1 patient cells (Table 1).  
The N-terminal domain of SUN1 faces the nucleoplasm. It provides an interaction site for 
Lamin A (residues 1-138) and Emerin and Nesprin-2 (residues 209-302) (Haque et al., 2010). 
Furthermore, the N-terminal domain also binds to chromatin (Xiong et al., 2008). The A203V 
mutation in SUN1 is not contained in these binding sites; however the mutant protein when 
expressed in wild-type fibroblasts or from both patient fibroblasts showed an impaired 
interaction with Emerin and Lamin A/C (Tables 1-2).  
Taken together, our results highlight the interactions at the NE. Mutations in the EMD and 
TMPO gene in combination with mutations in SUN1 have an impact on several components 
of the network and affect both cellular properties as well as expression levels of NE proteins 
which themselves then can result in changes thus revealing various interdependencies. 
 
3.2 Inner nuclear envelope protein SUN1 plays a prominent role in 
mammalian mRNA export 
3.2.1 Both SUN1 and SUN2 interact with hnRNP F/H and hnRNP K/J which 
accumulate in the nucleus by SUN1 depletion   
The double membrane of the nucleus physically separates the nucleus from the cytoplasm, 
whereas the LINC complex composed of conserved SUN and KASH domain proteins of the 
NE mechanically bridges the nucleoskeleton and cytoskeleton. SUN1 and SUN2 are INM 
components of the LINC complexes with a conserved Sad1/UNC-84 homology SUN-domain 
at the C-terminus. 
The hnRNPs are RNA-binding proteins that associate with nascent transcripts produced by 
RNA polymerase II, and other RNA complexes (Dreyfuss et al., 1993). In human cells, about 
30 different hnRNPs associate with pre-mRNAs in the nucleus. These proteins (hnRNP A1-
U) with a molecular weight of ~34-120 kDa are highly abundant in the nucleus (Dreyfuss et 
al., 2002; Pinol-Roma and Dreyfuss, 1993). They affect multiple aspects of pre-mRNA 
processing and mRNA metabolism including the packaging of nascent transcripts, alternative 
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splicing, nucleocytoplasmic transport and translational regulation. Although they have some 
common characteristics, they differ from each other in domain composition and functional 
properties (Han et al., 2010).  
The hnRNP F/H include hnRNP F, H1 (H), H2 (H) and H3 (2H9) and have highly similar 
sequence, structure and binding preferences. All the hnRNPs contain RBDs (RNA binding 
domain), however, compared to most hnRNPs, hnRNP F/H have different RBDs named as 
qRRMs (quasi-RNA recognition motif) (Honore et al., 1995). Moreover, hnRNP F/H 
specificly bind to poly(G) in vitro which is a characteristic different from others (Matunis et 
al., 1994). The hnRNP F/H are well known for their function in the regulation of alternative 
splicing, whereby the binding sites of hnRNP F/H improve the splicing of an enlarged intron 
and modulate the selection of splice-sites (Martinez-Contreras et al., 2006). 
In eukaryotic cells, pre-mRNAs are synthesized in the nucleus by RNA polymerase II and 
after series of processing they are transported to the cytoplasm for translation. Therefore, 
another key difference between the hnRNPs is that some of them shuttle between the nucleus 
and the cytoplasm (Pinol-Roma and Dreyfuss, 1992). This was originally assumed as a means 
of transporting mRNA into the cytoplasm and there are evidences supporting the link between 
hnRNPs transport and mRNA export. First, it was reported that a subset of hnRNPs, including 
hnRNP A1, A2, D, E, I and K, continuously shuttle, accompanied by some mRNA export 
factors, between the nucleus and the cytoplasm (Michael et al., 1995b; Pinol-Roma and 
Dreyfuss, 1992; Pinol-Roma and Dreyfuss, 1993). Second, mRNA translocating through the 
NPC is directly associated with shuttling hnRNPs (Visa et al., 1996). Third, hnRNP A1 with a 
nuclear export signal (NES) has been identified as a direct player involved in mRNA export 
(Izaurralde et al., 1997; Michael et al., 1995a). 
One of such shuttling hnRNPs related to our finding is hnRNP K. The structure of hnRNP K 
is grossly different from the others in that it contains three KH (K homology) domains rather 
than RRMs (RNA recognition motifs) or RRM-like domains. Due to its special structure, 
hnRNP K plays an important role in many aspects of mRNA metabolism, including mRNA 
silencing (Ostareck et al., 2001; Ostareck et al., 1997), transcription (Lynch et al., 2005; 
Stains et al., 2005), splicing (Expert-Bezancon et al., 2002), regulation of mRNA stability 
(Fukuda et al., 2009) and translation (Habelhah et al., 2001; Mukhopadhyay et al., 2009). 
Therefore, hnRNP K functions in mRNA processing within the nucleus, and then 
accompanies the mRNA until it translocates through the NPC into the cytoplasm for 
participating in translation regulation, indicating that hnRNP K might be involved in mRNA 
export as well. 
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SUN1 and SUN2 are conserved type-II INM proteins and consist of an N-terminal, coiled-
coiled, transmembrane and SUN domain at the C-terminus which directly interacts with a 
KASH domain to form LINC complex in the lumen of the NE (Mejat and Misteli, 2010; Tzur 
et al., 2006; Worman and Gundersen, 2006). Obviously, the N-termini of SUN1 and SUN2 
are responsible for the association with the nucleoskeleton and other nuclear events. 
Therefore, we used the N-terminus of SUN protein for pulldown and LC-MS analysis so as to 
find new interacting partners (Taranum et al., 2012). Our results that the N-termini of SUN1 
and SUN2 interact with hnRNP F/H and hnRNP K/J in vitro suggest that the N-termini of 
SUN proteins might be associated with mRNA biogenesis according to the functions of 
hnRNP F/H and hnRNP K/J. In vivo, these hnRNPs can be precipitated by full length GFP-
SUN1 and GFP-SUN2 indicating that SUN1 and SUN2 interact with hnRNP-mRNA 
complexes in the nucleus. Considering that SUN1 and SUN2 are anchored in the INM, they 
might play a crucial role in mRNA biogenesis at a late stage, such as mRNA export. 
Consistently, immunofluorescence analysis showed that endogenous SUN1 and SUN2 
colocalized with hnRNP F/H and hnRNP K/J only at the NE.  
The hnRNP proteins accompany mRNP at different stages during mRNP export (Dreyfuss et 
al., 2002). Before an mRNP translocates through the NPC, the nuclear restricted hnRNPs 
containing nuclear-retention signals start to get released from the mRNP and stay in the 
nucleus, whereas the shuttling hnRNPs will accompany the mRNA through the NPC channel 
and into the cytoplasm (Carmody and Wente, 2009; Dreyfuss et al., 2002) (Figure 1.7). 
Therefore, the shuttling hnRNPs become an important marker reflecting the efficiency of 
mRNA export. One such well known shuttling hnRNP involved in our study is hnRNP K 
(hnRNP F/H were unknown until now), which interacts with both SUN1 and SUN2.  
Knockdown is a general tool for studying the function of proteins. To confirm our hypothesis 
that SUN proteins are involved in mRNA export, we performed knockdown studies of SUN1 
using siRNA. Based on the efficient SUN1 knockdown, we can see remarkably altered 
distributions of hnRNPs by performing subcellular fractionation experiment in control and 
SUN1 knockdown cells. Our results showed that all the studied hnRNPs, especially hnRNP 
K, accumulated in the nuclear fraction and reduced in the cytosolic fraction as compared to 
negative controls, indicating that SUN1 depletion affects the nucleocytoplasmic transport of a 
shuttling hnRNP protein, hnRNP K, supposed to be a marker of mRNA export. Besides, 
Lamin A/C, an interaction partner of SUN1, was reported to interact with hnRNP E1 (Zhong 
et al., 2005), another well-known shuttling hnRNP protein (Chkheidze et al., 1999; Dreyfuss 
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et al., 2002; Kiledjian et al., 1995), that strongly supports our hypothesis that SUN1 functions 
in mRNA export via either direct or indirect interactions. 
 
3.2.2 SUN1 is important for mRNA export 
In previous studies, nuclear mRNA export in higher eukaryotes was studied mainly using two 
methods, microinjection of specific antibodies into Xenopus oocytes and overexpression 
transfection assays in mammalian cells. Although both methods are powerful for analysing 
poly(A)+RNA in vivo, there exist still limitations. For example, one needs to purify the 
protein of interest and produce specific antibodies for injection. Based on these methods, one 
can find out whether a protein of interest promotes or inhibits nuclear mRNA export, but 
cannot tell whether this protein is essential for this pathway. Later on, the discovery of RNAi 
solved these problems in higher eukaryotes by transiently silencing of specific gene. 
Our observations that hnRNP F/H and hnRNP K accumulate in the nucleus after SUN1 
depletion provide a clue that SUN1 might participate in hnRNP involved mRNA export. To 
directly find out whether SUN1 is important for mammalian mRNA export, we performed 
RNA FISH analysis after SUN1 knockdown. Our results showed that the poly(A)+RNA 
distribution was altered in SUN1 knockdown cells, whereby poly(A)+RNA strongly 
accumulated in SUN1 depleted nucleus compared to the control. Further, a rescue study 
performed in mRNA export deficient cells confirmed that SUN1 depletion resulted in an 
mRNA export defect. The defective phenotype was not due to off-target effects. Thus, we 
conclude that SUN1 has an important role in mRNA export. 
 
3.2.3 SUN1 functions in mRNA export independent of the CRM1-dependent 
export pathway 
Recently, mRNA export has been roughly divided into two forms: bulk and specific export 
according to the different export receptors (Culjkovic-Kraljacic and Borden, 2013). The 
export receptor NXF1 mediates the export of most constitutively expressed mRNAs, named 
as NXF1-dependent pathway (bulk export). Another export receptor, CRM1, mediates the 
export of specialized subsets of mRNAs, UsnRNAs, rRNAs, and SRP RNA, named as 
CRM1-dependent pathway (specific export) (Natalizio and Wente, 2013). Obviously, we have 
to ask what kind of mRNAs require SUN1 for export and in which export pathway SUN1 is 
involved.  
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For answering these questions, specific inhibitors are required to block one of the pathways. 
Luckily, LMB, a well-known inhibitor of CRM1, is available which can directly block the 
CRM1-dependent pathway (Herold et al., 2003; Kudo et al., 1998). Therefore, we used LMB 
to block the CRM1-dependent export under RNAi condition and compared the distribution of 
poly(A)+RNA in both LMB untreated and treated cells. For each trial, the 
nuclear/cytoplasmic (N/C) ratio of the poly(A)+RNA distribution was determined by 
measuring fluorescence intensity. Without LMB treatment, the N/C ratios of most control 
siRNA cells are centered at the range [0.9-1.3) with a mean value of ∼1.15 which is similar as 
previously reported in HeLa control cells (Folkmann et al., 2013). Interestingly, the N/C ratios 
of SUN1 siRNA cells were increased up to ~1.63 reflecting higher nuclear accumulation of 
poly(A)+RNA. After treatment with 7 ng/ml of LMB, the N/C ratios of both control- and 
SUN1 siRNA-transfected cells were significantly increased with the mean value up to ~1.56 
and ~1.84, respectively. In control siRNA cells, the increase after LMB treatment means that 
the drug treatment worked under our experimental conditions. Most surprisingly, in SUN1 
siRNA cells, the further increase after LMB treatment indicates that LMB caused additional 
nuclear accumulation of poly(A)+RNA apart from that due to SUN1 depletion. Therefore, we 
conclude from the additional accumulation that SUN1 plays a role in mRNA export 
independent of the CRM1-dependent pathway, which in turn suggests SUN1 might participate 
in the NXF1-dependent pathway. 
 
3.2.4 NXF1 mediates the association between SUN1 and mRNP 
In higher eukaryotes, NXF proteins exist as a protein family encoded by the amplification of 
nxf genes. There is only one NXF protein encoded by yeast genome, Mex67p, but there are 
two NXFs in Caenorhabditis elegans and four in Drosophila melanogaster and Homo 
sapiens. However, the best known NXF protein is NXF1 (Mex67p in yeast) which has an 
essential role in bulk mRNA export (reviewed in (Izaurralde, 2002)). 
Based on previous results we assume that SUN1 might be involved in the NXF1-dependent 
mRNA export pathway. In eukaryotic cells, the formation of mRNP complex is the first step 
of mRNA export (Carmody and Wente, 2009). Oligo dT pulldown experiment showed that 
endogenous SUN1 and NXF1 specifically copurified with the poly(A) fraction, as did SUN2, 
hnRNP K and hnRNP H, but not hnRNP F, suggesting SUN1 associates with NXF1-
containing nuclear mRNP, either directly or indirectly through other proteins. 
Since the essential role of NXF1 in mRNA export is well established in different species, we 
supposed that SUN1 associates with mRNP complex through the connection with NXF1. In 
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order to prove this point, several studies related to SUN1 and NXF1 were designed and 
implemented. Interestingly, the results indeed reveal that SUN1 is directly related to NXF1 in 
many ways. For instance, SUN1 depletion down regulates the expression level of NXF1, 
SUN1 and NXF1 directly interact with each other in vitro and NXF1 exhibits aggregate-like 
staining along with GFP-SUN1-NT. Importantly, the N-terminus of SUN1 is essential for 
these associations.  These results highlight our hypothesis that SUN1 associates with mRNP 
cargo through a direct interaction with NXF1 which is recruited to the mRNP in the nucleus 
prior to export.    
 
3.2.5 SUN1 hands the mRNP over to the NPC component Nup153 
The second step in mRNA export is the mRNP targeting and translocating through the central 
channel of the NPC. Considering our finding that SUN1 directly interacts with NXF1 and that 
it is present at the NE, we assume that SUN1 supports mRNA export by recruiting NXF1-
containing mRNP onto the NE and then hands it over to the NPC. Therefore, we continued 
our studies towards a connection between SUN1 and NPC. Although several reports indicate 
that SUN1 is important for the assembly and distribution of the NPC (Chang et al., 2015; Liu 
et al., 2007; Talamas and Hetzer, 2011), there is no evidence related to SUN1 and NPC-
mediated mRNA export. In order to find out what is the connection between SUN1 and NPC, 
we performed several protein-protein interaction studies in vitro. The results showed that 
SUN1 but not SUN2 interacted with Nup62, Nup153 and Nup214 detected by mAb414 
antibodies and that SUN1 exhibited a preference for Nup153. These results indicate that 
SUN1 associates with the NPC through either direct or indirect interaction with a subset of 
nucleoporins, such as Nup62, Nup153 and Nup214.  
Nup153 is named for its predicted mass (Galy et al., 2003; Harborth et al., 2001) as is for 
most nucleoporins, localized at the nuclear basket of the NPC (Sukegawa and Blobel, 1993) 
and composed of the N- terminal, Zinc finger and C-terminal domain. The N-terminal domain 
(1–610) of Nup153 is unique and contains three overlapping regions involved in Nup153 
localization and RNA binding, that are a nuclear envelope targeting cassette (NETC, 2–144) , 
nuclear pore associating region (NPAR, 39–339) and a RNA binding domain (250–400) 
(Bastos et al., 1996; Enarson et al., 1998). The zinc finger domain (650–880) contains four 
C2–C2 type zinc fingers which have been reported to associate with DNA (Sukegawa and 
Blobel, 1993), and they are similar to those found in Nup358 (Wu et al., 1995; Yokoyama et 
al., 1995). The C-terminal domain of Nup153 contains FG repeats similar to several other 
nucleoporins, where F is phenylalanine, and G is glycine (Denning et al., 2003). 
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To date, apart from vertebrate pore proteins Nup98, Nup133, Nup160, Tpr, and 
CAN/Nup214, Nup153 has been identified to associate with mRNA export (Dimaano and 
Ullman, 2004; Kohler and Hurt, 2007). Nup153 is unique among the vertebrate pore proteins 
since it contains an RNA binding domain (250–400) which has the ability to directly bind to 
RNA (Dimaano et al., 2001). The RNA binding ability of Nup153 is conserved in Drosophila, 
Xenopus and human proteins (Dimaano et al., 2001), and it was found to preferentially bind 
single-stranded RNA, that refers to mRNA (Ball et al., 2004).  
Thus, we extended our interaction studies to SUN1 and Nup153. According to the domain 
structure of Nup153, a series of polypeptides which contain the N-terminal, Zinc finger and/or 
C-terminal domain were used in the experiment. The results showed that Nup153 interacts 
directly with SUN1, and both the N- and C-terminus are important for this binding. Therefore, 
we concluded that SUN1 associates with the NPC through a direct interaction with Nup153 
which plays an important role in mRNA export. 
Additionally, it was reported that Nup153 is highly mobile and presents at different parts of 
the pore as well as in the interior of the nucleus (Daigle et al., 2001; Griffis et al., 2004). This 
strongly supports our hypothesis that SUN1 recruits NXF1-containing mRNP onto the NE 
and then hands it over to the NPC.  
One prediction of our hypothesis is that SUN1 hands the mRNP over to the NPC component 
Nup153. Therefore there should be some connections between mRNP and Nup153. Indeed, 
these connections exist. Nup153 is able to recognize two parts of the mRNP, a single-stranded 
stretch of mRNA and the mRNA export receptor NXF1 which can interact with the C-
terminal region of Nup153 (Bachi et al., 2000). Moreover, SUN1 hands the mRNP over to 
Nup153 for which several ways can be imagined. First, Nup153 interacts with NXF1 which 
could lead to a release of mRNP from SUN1, however this is in conflict with our finding that 
SUN1 directly interacted with Nup153; second, Nup153 interacts with SUN1 to set free the 
NXF1-containing mRNP and transfer it to Nup153, but this also looks rather unlikely 
considering that SUN1 showed a preference for NXF1 in the presence of Nup153 (data not 
shown); third, Nup153 simultaneously interacts with SUN1 and NXF1 leading to mRNP 
release from SUN1 and a direct transfer to Nup153. Such a scenario would well agree with 
our data.  
Once the mRNP targets the NPC, it starts to translocate through the central channel of the 
NPC and be released into the cytoplasm for translation. Interestingly, Nup153 might be still 
involved in this process. There is evidence that Nup153 is not only localized at the nuclear 
basket of the NPC. Immuno-gold labelled antibodies and epitope-tagged versions of Nup153 
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were used for the examination. The N-terminal epitope tag was detected at the nuclear coaxial 
ring, while the C-terminus was distributed both in the basket and on the cytoplasmic side of 
the pore, suggesting that the C-terminal region is flexible and is not fixed at a point within the 
pore (Fahrenkrog et al., 2002). Similarly, several FG-rich domains were measured by 
biophysical methods and the results showed that these regions are natively unfolded and exist 
in a balance between many conformations (Denning et al., 2003). Additionally, Nup153 
shuttles between the nuclear and cytoplasmic faces of the NPC since it contains an M9 
shuttling domain, M9-type NLS, at the N-terminus (Nakielny et al., 1999). Thus, Nup153 
might support mRNP to translocate through the NPC by its C-terminus.  
Taken together, mRNA is transcribed by RNA polymerase II, packaged into mRNP by 
hnRNPs and other RNA binding proteins, then spliced and processed to form mature mRNA 
(mRNP). The mRNP is labelled by NXF1 in the nucleus and recruited onto the NE by the 
INM protein SUN1. Prior to the export from the NPC, the nuclear restricted hnRNPs and 
other RNA binding proteins are released from the mRNP and stay in the nucleus, whereas the 
shuttling hnRNPs accompany the mRNA into the cytoplasm. Finally, SUN1 hands over the 
mRNP to the NPC component Nup153, which most likely translocates the mRNP cargo 
through the NPC either directly by itself or indirectly together with other proteins. 
This is consistent with a model for SUN1 functions in mammalian mRNA export whereby 
SUN1, acting as a docking point, recruits NXF1-containing mRNP onto the NE, and hands it 
over to the NPC component Nup153 which enables the nuclear mRNA export to be 
performed systematically (Figure 3.1). 
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Figure 3.1: A model of SUN1 functions in mammalian mRNA export. We propose that SUN1 acts as a 
docking point to recruit NXF1-containing mRNP onto the NE and hands it over to Nup153. 
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4. Summary  
Mutations in several genes encoding nuclear envelope associated proteins cause Emery-
Dreifuss muscular dystrophy (EDMD). We analyzed fibroblasts from a patient who had a 
mutation in the EMD gene (p.L84Pfs*6) leading to loss of Emerin and a heterozygous 
mutation in SUN1 (p.A203V). The second patient harbored a heterozygous mutation in 
LAP2alpha (p.P426L) and a further mutation in SUN1 (p.A614V). p.A203V is located in the 
N-terminal domain of SUN1 facing the nucleoplasm and situated in the vicinity of the 
Nesprin-2 and Emerin binding site. p.A614V precedes the SUN domain which interacts with 
the KASH domain of Nesprins in the periplasmic space and forms the center of the LINC 
complex. At the cellular level we observed alterations in the amounts for several components 
of the nuclear envelope (NE) in patient fibroblasts and further phenotypic characteristics 
generally attributed to laminopathies such as increased sensitivity to heat stress. The defects 
were more severe than observed in EDMD cells with mutations in a single gene. In particular, 
in patient fibroblasts carrying the p.A203V mutation in SUN1 the alterations were aggravated. 
Moreover, both patient fibroblasts exhibited reduced interaction of SUN1 with Lamin A/C 
and when expressed ectopically in wild-type fibroblasts the SUN1 mutant proteins exhibited 
reduced interactions with Emerin as well. 
Nuclear export of mRNPs through the NPC can be roughly classified into two forms: bulk 
and specific export, involving an NXF1-dependent pathway and CRM1-dependent pathway, 
respectively. Here, we show that mammalian cells require SUN1 for efficient nuclear mRNP 
export. The results show that both SUN1 and SUN2 interact with hnRNP F/H and hnRNP 
K/J. SUN1 depletion inhibits the mRNP export, with accumulations of both hnRNPs and 
poly(A)+RNA in the nucleus. LMB treatment indicates that SUN1 functions in mRNA export 
independent of the CRM1-dependent pathway. SUN1 mediates mRNA export through its 
association with mRNP complex by a direct interaction with NXF1. Overexpression of GFP 
fused SUN1 N-terminus leads to the formation of GFP-SUN1-NT positive aggregates which 
contain NXF1. Additionally, SUN1 associates with the NPC through a direct interaction with 
Nup153, a nuclear pore component involved in mRNA export. Taken together, our results 
reveal that the INM protein SUN1 has additional functions aside from being a central 
component of the LINC complex and that it is an integral component of the mammalian 
mRNA export pathway suggesting a model whereby SUN1 recruits NXF1-containing mRNP 
onto the nuclear envelope, and hands it over to Nup153. 
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Zusammenfassung 
Mutationen in Genen für verschiedene Kernhülle assoziierte Proteine verursachen Emery-
Dreifuss muskuläre Dystrophie (EDMD). Wir haben Fibroblasten eines Patienten mit einer 
Mutation im EDM Gen (p.L84Pfs*6), die zum Verlust von Emerin führt, analysiert. Dieser 
Patient ist zusätzlich heterozygot für eine Mutation im SUN1 Gen (p.A203V). Ein zweiter 
Patient ist heterozygot für eine Mutation im LAP2alpha Gen (p.P426L) und hat eine 
zusätzliche Mutation im SUN1 Gen (p.A614V). Die p.A203V Mutation verursacht einen 
Aminosäureaustausch in der N-terminalen Domäne von SUN1, welche sich im Nucleoplasma 
in der Nähe der Bindestelle von Nesprin-2 und Emerin befindet. Die p.A614V Mutation 
befindet sich vor der SUN Domäne, welche mit der KASH Domäne von Nesprinen im 
perinukleären Raum interagiert und die zusammen das Zentrum des LINC-Komplexes bilden. 
Auf zellulärem Niveau weisen die Fibroblasten des Patienten Änderungen in den Mengen 
mehrerer Bestandteile der Kernhülle auf, weiterhin sind für Laminopathien charakteristische 
phänotypische Eigenschaften wie eine erhöhte Empfindlichkeit gegenüber Hitzestress zu 
beobachten. Diese Schäden waren schwerwiegender als in EDMD Zellen mit Mutationen in 
nur einem Gen. Insbesondere Patienten-Fibroblasten mit der p.A203V-Mutation im SUN1 
Gen weisen schwerere Defekte auf. Zusätzlich hierzu interagierte das SUN1 Protein in den 
Fibroblasten beider Patienten schwächer mit Lamin A/C. Die mutierten SUN1 Proteine 
zeigten ebenfalls eine reduzierte Interaktion mit Emerin nach ektopischer  Expression in 
Wildtyp-Fibroblasten.  
Der Export von messenger Ribonukleoproteinen (mRNPs) aus dem Zellkern wird in zwei 
Gruppen eingeteilt: unspezifischer NXF1-abhängiger Export und spezifischer CRM1-
abhängiger Export. Wir zeigen hier, dass Säugerzellen SUN1 benötigen, um einen effektiven 
mRNP Export durchzuführen. Sowohl SUN1 als auch SUN2 interagiert mit hnRNP F/H und 
HnRNP K/J. Knock-down der SUN1 Expression hemmt den mRNP Export und hat eine 
Anhäufung von hnRNPs und poly(A)+RNA im Zellkern zur Folge. Zusätzlich zeigte die 
Behandlung der Zellen mit LMB, dass die den mRNA Export betreffende Funktion von 
SUN1 von CRM1 unabhängig ist. Durch Assoziation mit mRNP Komplexen und durch eine 
direkte Interaktion mit NXF1 vermittelt SUN1 den Export von mRNP aus dem Zellkern. Die 
Überexpression der SUN1 N-terminalen Domäne als GFP-Fusionsprotein führt zur Bildung 
von GFP-positiven Aggregaten, in die NXF1 rekrutiert wird. Zusätzlich, interagiert SUN1 
direkt mit Nup153, einer Komponente des Kernporenkomplexes, welche am mRNA Export 
beteiligt ist. 
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Zusammengenommen zeigen unsere Ergebnisse eine Rolle von SUN1 im mRNA Export und 
implizieren ein Model, in dem SUN1 NXF1 enthaltende mRNP-Komplexe zur Kernhülle 
rekrutiert und diese an Nup 153 übergibt. 
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5. Materials and Methods 
5.1 Materials 
5.1.1 Human cells 
HeLa  Human cervical cancer cell line 
Wild-type fibroblast   Human primary fibroblasts from skin 
Patient fibroblast Human primary fibroblasts from skin 
 
5.1.2 Bacterial strains 
E. coli XL1-Blue  (Bullock et al., 1987) 
E. coli ArcticExpress RIL      Stratagene GmbH 
 
5.1.3 Vectors and plasmids 
pGEM-T Easy       Promega 
pGEX-4T-1       GE Healthcare GmbH 
pEGFP-C2       Clontech 
GFP-SUN1        (Lu et al., 2008) 
GST-SUN2-NT       (Taranum et al., 2012) 
Sun2-V5-His        (Lu et al., 2008) 
GST-CT-ΔLamin A/C      (Libotte et al., 2005) 
GST-Nup153-(N, N+Zn, Zn, Zn+C, C)    Prof. Birthe Fahrenkrog  
 (Institute for Molecular Biology and Medicine, Université Libre de Bruxelles, Charleroi, Belgium) 
GST-NXF1        Prof. Stuart A Wilson  
(Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK) 
 
5.1.4 Oligonucleotides 
Oligonucleotides used in this thesis were ordered from Sigma and are listed below. 
Gene Sequence 
Lamin B1 (qRT) 
Fw 5´-CGAAAGATGCAGCTCTTGCTACTGCAC-3´ 
Rv 5´-CTCACTTGGGCATCATGTTGCTCTCTC-3´ 
SUN1 (qRT) 
Fw 5´-GAGTGGACGTGCAAGTCAGAGAAATGG-3´ 
Rv 5´-AGTACTCAAGATGCTGCCACCACCAGA-3´ 
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SUN2 (qRT) 
Fw 5´-GGACCTTGAAGAGGAAATCCAGCAACA-3´ 
Rv 5´-CGAGCCTCTTCCTTCACTGTCTTCCAC-3´ 
LAP2 (qRT) 
Fw 5´-AAGAGTGAGTTGGTCGCCAACAATGTG-3´ 
Rv 5´-TGGTTGTTCCCACAATAGGACCAGGAT-3´ 
Nesprin-2 (qRT) 
Fw 5´-AAGATTTAATGGCCTTGCAGGGAACC-3´ 
Rv 5´-GGGTAAAAGGACCGGGCAAAGTTGT-3´ 
SUN1 siRNA 5´-UUACCAGGUGCCUUCGAAA-3´ 
GFP-SUN1 
A203V
 
Fw 5´-GTGCTCACGGCGCACCCCGTGGCCCCCGGGCCCGTGTCG-3´ 
Rv 5´-CGACACGGGCCCGGGGGCCACGGGGTGCGCCGTGAGCAC-3´ 
Sq 5´-ACAACGGCTTCTCCTGCAGCAACT-3´ 
GFP-SUN1 
A614V 
Fw 5´-GCTGTGAGCGAGGCGGGGGTGTCTGGAATAACAGAGGCG-3´ 
Rv 5´-CGCCTCTGTTATTCCAGACACCCCCGCCTCGCTCACAGC-3´ 
Sq 5´-TGCGGAACGTCACCCACCACGTTT-3´ 
GFP/GST- 
SUN1-NT(1-239) 
Fw 5´-GAATTCATGGATTTTTCTCGGCTTCACATGTACAGT-3´ 
Rv 5´-GAATTCCTCGAGGGTCCCTGCCCGACCGGGGTGCGCGTC-3´ 
GFP-SUN1
R-3
 
Fw 
5´-GATTTCTTGGCTGAATGTGTTTCTTCTAACGAGATGCCTTCG 
AAACATCTG-3´ 
Rv 
5´-CAGATGTTTCGAAGGCATCTCGTTAGAAGAAACACATTCAG 
CCAAGAAATC-3´ 
GFP-SUN1
R-6
 
Fw 
5´-AATGTGTTTCTTCTAACGAGATGTCTACGTAACATCTGCAAG 
TTTTTAGTCTTG-3´ 
Rv 
5´-CAAGACTAAAAACTTGCAGATGTTACGTAGACATCTCGTTA 
GAAGAAACACATTC-3´ 
 
5.1.5 Enzymes 
Taq polymerase      GE Healthcare GmbH 
T4 DNA       ligase Life technologies™ Corp. 
Restriction endonucleases      New England Biolabs 
Ribonuclease A (RNase A)     Sigma Aldrich Corp. 
Calf Intestinal Alkaline Phosphatase (CIP)    Boehringer 
Pfu DNA Polymerase      Promega 
PreScission protease      GE Healthcare GmbH 
Thrombin       Amersham 
Trypsin       Invitrogen 
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5.1.6 Kits 
pGEM-T easy Cloning Kit      Promega 
NucleoSpin Extraction Kit      Macherey Nagel 
Pure Yield
TM
 Plasmid System     Promega 
Qiagen Midi- and Maxi-prep      Qiagen 
M-MLV reverse transcriptase RNase H Minus-kit   Promega 
QuantiTect
TM
 SYBR
®
 Green PCR Kit    Qiagen 
CLB-Transfection™ System      Lonza 
 
5.1.7 Antibiotics 
Ampicillin        Sigma Aldrich Corp. 
Kanamycin        Sigma Aldrich Corp. 
Penicillin/Streptomycin      Biochrom 
Gentamycin (G418)       GE Healthcare GmbH 
 
5.1.8 Chemicals 
1kb plus DNA ladder       Promega 
1,4-Dithiothreitol (DTT)  Gerbu Biotechnik GmbH 
4',6-diamidino-2-phenylindole (DAPI)    Sigma Aldrich Corp. 
5-Bromo-4-chlor-3-indolyl-β-D-galactopyranosid (X-Gal)  Carl Roth 
Acetic acid (98-100 %)  Sigma Aldrich Corp. 
Acrylamide        National Diagnostics Inc. 
Agarose (Electrophoresis Grade)     Life technologies™ Corp. 
Ammonium peroxide sulfate (APS)     Carl Roth 
β-Mercaptoethanol       Sigma Aldrich Corp. 
Boric acid        Merck KGaA 
Bovine serum albumin (BSA)     Sigma Aldrich Corp. 
Bromphenolblue (Na-Salt)      Serva Electrophoresis 
Calcium chloride       Merck KGaA 
Chloroform         Sigma Aldrich Corp. 
Cobalt chloride       Sigma Aldrich Corp. 
Complete mini protease inhibitor cocktail    Sigma Aldrich Corp. 
Coomassie-Brilliant-Blue R250     Serva 
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DAPI         Sigma Aldrich Corp. 
Deoxyribonucleotide triphosphates (dNTP)     Sigma Aldrich Corp. 
Dextran sulfate       Sigma Aldrich Corp. 
Diazabicyclooctane (DABCO)     Sigma Aldrich Corp. 
Dimethylformamide (DMF)      Sigma Aldrich Corp. 
Dimethylsulfoxide (DMSO)      Merck KGaA 
Dulbecco´s Modified Eagle´s Medium (DMEM)   Pan biotech 
Dynabeads
®
 Oligo (dT)25      Life technologies™ Corp. 
Ethanol (98-100 %)     Riedel de Haen 
Ethidium bromide     Sigma Aldrich Corp. 
Ethylen diamine tetra acetic acid (EDTA)    Merck KGaA 
Fetal calf serum (FCS)      Biochrom 
Formaldehyde     Sigma Aldrich Corp. 
Formamide     Merck KGaA 
Gelvatol     Pfizer Inc. 
Glycine     Sigma Aldrich Corp. 
Herring sperm DNA       Fluka 
Isopropanol     Sigma Aldrich Corp. 
Isopropyl-D-thiogalactopyranoside (IPTG)    Loewe Biochemica GmbH 
Leptomycin B      Sigma Aldrich Corp. 
Low molecular weight (LMW) protein marker   GE Healthcare GmbH 
Luminol     Sigma Aldrich Corp. 
Magnesium chloride     Merck KGaA 
Methanol     Sigma Aldrich Corp. 
N,N,N’,N’-Tetramethylethylenediamine (TEMED)   Merck KGaA  
Nonylphenyl-polyethyleneglycol (NP-40)    Sigma Aldrich Corp. 
N-[2-Hydroxyethyl] piperazine-N’-2  
-ethanesulfonic acid (HEPES)     Biomol GmbH 
p-cumaric acid        Sigma Aldrich Corp. 
PageRuler Plus Prestained Protein Ladder    Thermo Scientific Inc. 
Phenol      Carl Roth 
Phenylmethylsulphonylfluoride (PMSF)     Sigma Aldrich Corp. 
Polyoxyethylene-sorbitan monolaurate (Tween-20)   Sigma Aldrich Corp. 
Polyvinyl alcohol     Sigma Aldrich Corp. 
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Ponceau S Concentrate      Sigma Aldrich Corp. 
Potassium acetate      Sigma Aldrich Corp. 
Potassium chloride      Sigma Aldrich Corp. 
Potassium dihydrogen phosphate      Sigma Aldrich Corp. 
Sodium acetate      Merck KGaA 
Sodium chloride      Sigma Aldrich Corp. 
Sodium dodecyl sulfate (SDS)     Serva Electrophoresis 
Sodium hydroxide     Sigma Aldrich Corp. 
t-octylphenoxypolyethoxyethanol (Triton X-100)   Sigma Aldrich Corp. 
Tris (hydroxymethyl) aminomethane      Sigma Aldrich Corp. 
tRNA         Roche 
Trypan blue      Sigma Aldrich Corp. 
Vanadyl ribonucleoside complexes     Sigma Aldrich Corp. 
X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) Roth 
 
5.1.9 Primary antibodies 
Rabbit polyclonal anti-pAbK1     (Libotte et al., 2005) 
Rabbit polyclonal anti-Lamin B1     Abcam 
Rabbit polyclonal anti-Lamin A/C     Santa Cruz 
Rabbit polyclonal anti-Nesprin-1 (SpecII)    (Taranum et al., 2012) 
Rabbit polyclonal anti-Pericentrin     Abcam 
Mouse monoclonal anti-GFP (K3-184-2)    (Noegel et al., 2004) 
Mouse monoclonal anti-Emerin (4G5)    Abcam 
Mouse monoclonal anti-LAP2    BD Transduction Laboratories  
Rabbit monoclonal anti-SUN1     Abcam  
Rabbit monoclonal anti-SUN2     Abcam  
Mouse monoclonal anti-NPC (Mab414)    Abcam  
Mouse monoclonal anti-hnRNP F/H     ImmuQuest  
Mouse monoclonal anti-hnRNP K/J     ImmuQuest 
Mouse monoclonal anti-NXF1     Abcam 
Mouse monoclonal anti-Nup153 (QE5)    Abcam  
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5.1.10 Secondary antibodies 
Goat anti-mouse IgG, Alexa 488 conjugated   Life technologies™ Corp. 
Goat anti-rabbit IgG, Alexa 488 conjugated    Life technologies™ Corp. 
Goat anti-mouse IgG, Alexa 568 conjugated   Life technologies™ Corp. 
Goat anti-rabbit IgG, Alexa 568 conjugated    Life technologies™ Corp. 
Donkey anti-goat IgG, Alexa488 conjugated   Life technologies™ Corp. 
Anti-mouse IgG, peroxidase conjugated    Sigma Aldrich Corp. 
Anti-rabbit IgG, peroxidase conjugated    Sigma Aldrich Corp. 
 
5.2 Molecular biological methods 
5.2.1 Polymerase Chain Reaction (PCR) 
The PCR is a powerful tool used in molecular biology to amplify DNA fragments from a 
template double stranded DNA (dsDNA). In order to perform PCR, one needs in addition to 
the template DNA, the DNA polymerase (Taq polymerase), deoxyribonucleotides (dNTPs), 
and primers. After denaturation of the template DNA at high temperature, the reaction 
mixture is cooled down to allow annealing of the primers. The Taq polymerase then extends 
the primers and synthesizes a complementary strand. These steps are repeated for many 
cycles. A “standard program” is presented below.  
 
Standard PCR reaction set up 
x µl template-DNA 
2 µl forward primer (10 pmol/µl) 
2 µl reverse primer (10 pmol/µl) 
1 µl dNTP-mix (10 mM) 
5 µl 10x PCR buffer 
1 µl Taq polymerase (3-4 U) 
ad 50 µl dH2O 
 
Standard PCR program 
I. Initial denaturing 
Denaturing 
Annealing 
Extension 
II. Cycles 
III. Final extension 
IV. Cooling to 4°C 
 
94°C, 5 min 
94°C, 30 sec 
60-68°C, 30 sec 
72°C, 1-5 min 
25-35 
2°C, 10 min  
forever 
10x PCR buffer 
0.15 M Tris/HCl, pH 8.0 
  0.5 M KCl 
15 mM MgCl2 
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5.2.2 Site-directed mutagenesis 
The sequence of SUN1 corresponds to O94901 (NCBI), an isoform consisting of 812 amino 
acids. We used the plasmid human GFP-SUN1 full length (Lu et al., 2008) to produce the 
SUN1 mutant plasmids (GFP-SUN1A203V, GFP-SUN1A614V and siRNA resistant plasmid 
GFP-SUN1
R
) according to a site-directed mutagenesis kit (Promega). The mutagenic 
oligonucleotide primers were designed individually according to the desired mutation (shown 
in 4.1). Mutant strand synthesis reaction was performed by PCR and the standard reaction 
mixture and program are shown below. After the amplification, 1µl of the methylation 
sensitive Dpn I restriction enzyme (10 U/µl) was directly added to each reaction for digestion 
of the input DNA which is methylated whereas the newly synthesized DNA is not. The 
samples were incubated for 1 hour at 37°C. Transformation of XL1-Blue supercompetent 
cells was carried out afterwards. 
 
Site-directed mutagenesis PCR  Site-directed mutagenesis PCR program 
x µl (5-50 ng) template DNA I. Initial denaturing 95°C, 30 sec 
x µl (125 ng) forward primer  Denaturing 95°C, 30 sec 
x µl (125 ng) reverse primer  Annealing 55°C, 1 min 
1 µl dNTP-mix  
Extension 
68°C, 1 min/kb of 
plasmids length 5 µl 10x reaction buffer  
1 µl PfuUltra HF DNA polymerase (2.5U/µl) II. Cycles 12-18 
ad 50 µl dH2O III. Final extension 68°C, 10 min 
 IV. Cooling to 4°C forever 
 
5.2.3 Agarose gel electrophoresis of DNA 
Agarose gel electrophoresis was performed for separation and analysis of DNA fragments 
based on their size. Electrophoresis was performed with 0.7 %-1.2 % agarose gels in 1x TAE 
buffer with the fluorescent dye ethidiumbromide (2 μg/ml) which intercalates between bases 
of DNA. The gels were allowed to solidify and then submerged in a horizontal electrophoresis 
tank containing 1x TAE buffer. The DNA samples were mixed with 1/10 volume of a 10x 
DNA loading buffer and then pipeted into the sample wells. DNA size marker was always 
loaded along with the DNA samples and allowed to estimate the size of the resolved DNA 
fragments. The gels were visualized under UV light at 302 nm and photographed using a gel 
documentation system (Alpha Innotec). 
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1x TAE buffer 
 40 mM Tris (pH 7.6) 
 20 mM acetic acid 
   1 mM EDTA 
 
DNA loading buffer 
   40 % sucrose 
  0.5 % SDS 
0.25 % bromophenol blue in TE buffer, pH 8.0 
 
5.2.4 Ligation of DNA fragments 
Vector and fragment that were subjected to the same double digest were mixed in a final 
volume of 10 µl Ligation mixture (the molar ratio of vector: fragment = 1:3) and incubated at 
16°C overnight. 
 
Ligation mixture 
x μl linearized vector DNA 
x μl DNA fragment 
1 μl 5x ligation buffer 
1 μl T4 Ligase (1 U/μl) 
ad 10 μl with ddH2O 
5x Ligation buffer 
0.25 M Tris-HCl, pH 7.6 
50 mM MgCl2 
  5 mM ATP 
  5 mM DTT 
25% polyethylene glycol-8000 
 
5.2.5 Preparation of chemically competent E. coli cells 
Chemically competent E. coli cells were prepared using the calcium chloride method. 
A single colony was selected from an LB plate and grown overnight in 5 ml LB-medium at 
37°C with shaking (220 rpm). The pre-culture was added to 1 L LB-medium and grown to 
log-phase (OD600 0.4 - 0.6) at 37°C with shaking (220 rpm). The culture was chilled on ice for 
30 min and then centrifuged for 10 min at 1,500 g at 4°C. All following steps were performed 
on ice. The pelleted cells were resuspended in 50 ml ice-cold transformation buffer and 
incubated on ice for 10 min. The cells were harvested, resuspended in 20 ml ice-cold 
transformation buffer and 1.5 ml DMSO was added with gentle shaking. Aliquots of 200 μl 
cells were immediately frozen in liquid nitrogen and stored at -80°C until use. 
Transformation buffer, pH 6.7 
  10 mM PIPES 
  15 mM CaCl2 
250 mM KCl 
  55 mM MnCl2 
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5.2.6 Transformation of chemically competent E. coli cells 
Transformation of competent E. coli cells with plasmid DNA was performed by heat shock at 
42°C (Inoue et al., 1990). 200 µl of chemically competent cells were thawed on ice and mixed 
with plasmid DNA (10-40 ng) or ligation mixture. After 15 minutes incubation on ice, the 
cells were incubated at 42°C (heat shock) for 45 seconds then cooled down on-ice for 2 
minutes. For ArcticExpress RIL E. coli cells, the heat shock was performed for only 20 
seconds at 42°C. Afterwards, 800 µl preheated LB medium were added to the cells and 
incubation was at 37°C for 1 hour with shaking (220 rpm) without any antibiotics. Finally, the 
samples were centrifuged at 6,000 g for 2 min and 800 µl of the supernatant was discarded. 
The pelleted cells were resuspended and spread onto LB agar plates containing the 
appropriate antibiotic. Alternatively, for plasmid retransformation 50-100 µl of the cultured 
sample were directly spread on the LB agar plates. After overnight incubation at 37°C, 
colonies were picked for further analysis. 
 
5.2.7 Blue-white selection of transformants 
After cloning of the PCR-products into the pGEM-T Easy vector and transformation into E. 
coli XL1 Blue, cells were plated onto LB-ampicillin plates covered with 100 µl of LB-
medium containing 20 µl of 2 % X-Gal solution and 10 µl of 1 M IPTG, and incubated at 
37°C overnight. The next day, white positive colonies were selected for further analysis. 
 
1 M IPTG solution 
2.38 g IPTG 
ad 10 ml with ddH2O 
2 % X-Gal solution 
200 mg X-Gal 
ad 10 ml with dimethylformamid 
 
5.2.8 Colony PCR 
Single bacterial colonies were picked and cultured in LB medium for 6 h or overnight, then 1 
µl or 2 µl were taken as template for PCR with specific primers. The programme of the PCR 
reaction set up was as described in 4.2.1. 
 
5.2.9 DNA-Mini-preparation from E. coli (Birnboim et al., 1979) 
With this DNA isolation method plasmid DNA from small amounts (2 ml) of bacterial 
cultures was prepared. An overnight E. coli culture was centrifuged for 2 minutes (5000 g). 
The pellet was suspended in 300 μl B1, 300 μl B2 was added, mixed, incubated (5 min, RT), 
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300 μl B3 was added, mixed again and centrifuged for 15 minutes (14.000 g, RT). The 
supernatant was transferred to a new Eppendorf tube which contained 550 µl isopropanol for 
DNA precipitation. After 14.000 g centrifugation for 20 min at RT, the supernatant was 
discarded and the pellet air dried. Finally, the plasmid DNA was dissolved in 50 µl H2O. 
 
 B1 B2 B3 
50 mM Tris/HCl, pH 8.0  0.2 M NaOH 3 M KAc, pH 5.5 
10 mM EDTA 1% SDS  
100 μg/ml RNase   
 
5.2.10 Restriction analysis of DNA 
Restriction enzymes were purchased from New England Biolabs. 10 units enzyme were used 
for 50 ng - 1 μg of DNA and the digestions were usually performed in a final volume of 20 µl 
for 1-2 h at 37°C. 
 
5.2.11 DNA-Midi/Maxi preparation-Pure Yield
TM
 Plasmid System 
For the large amount of DNA preparation, Pure Yield
TM
 Plasmid System (Promega) was used 
and the buffer compositions are shown below. 
 
Cell Suspension Solution  Cell Lysis Solution 
50 mM Tris/HCl, pH 8.0 
10 mM EDTA 
0.2 M NaOH 
 1% SDS  
100 μg/ml RNase  
  
Neutralization solution column wash 
4.09 M Guanidinium hydrochloride 60% ethanol 
759 mM Potassium acetate 60 mM Potassium acetate 
2.12 M Glacial acetic acid 8.3 mM Tris/HCl; pH 7.5 
0.04 mM EDTA  
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5.2.12 Measurement of DNA and RNA concentrations  
Concentrations of DNA and RNA were estimated by determining the absorbance at a 
wavelength of 260 nm. A ratio of OD260/OD280 <1.8 (DNA) or <2 (RNA) indicates 
negligible protein contaminations. Protein contaminations were estimated from absorbance at 
280 nm.  
5.2.13 Isolation of total RNA with TRIzol
®
 
Total RNA was extracted from cells using TRIzol (Invitrogen). Briefly, the cells with a 
confluency of 70-80% were trypsinised and centrifuged in ice cold PBS at 1200 rpm for 5 
min. The pellet was suspended in 1 ml TRIzol per 50-100 mg cells and incubated at RT for 5 
min. For each ml of TRIzol 200 μl chloroform were added, mixed and incubated at RT for 2-3 
min followed by centrifugation at 12,000 g for 15 min. The aqueous phase was transferred 
into a new microcentrifuge tube. For each ml of solution 500 μl of isopropanol were added, 
mixed, incubated at RT for 10 min and centrifuged at 12,000 g for 10 min afterwards. The 
pellet was washed with 75% ethanol, vortexed and briefly centrifuged. After air drying, the 
pellet was dissolved in 50 μl of RNase-free water at 60°C for 10 min. Finally, the 
concentration and quality of the RNA was determined by Agilent Bioanalyser (Agilent 
Technologies) and stored at -80°C. 
5.2.14 cDNA synthesis 
First-strand cDNA synthesis was performed using the M-MLV reverse transcriptase RNase H 
Minus-kit (Promega). In brief, 1µg of total RNA was mixed with 2 µl of random primers (50 
µM pdN6, Stratagene) and filled up to 15 µl with nuclease free water. After incubation for 5 
min at 70°C and cooling down for 2 min on ice, 5 µl 5x reaction buffer (Promega), 1.25 µl 
dNTP’s (10 mM, Stratagene), 1 µl RNase inhibitor (RNasin 40 U/µl, Promega), 1.75 µl 
nuclease free water and 1 µl M-MLV-RT (200 U/µl) were added to the sample. The mixture 
were incubated for 1 h at 37°C and stored at -20°C until use. 
RT-Reaction Mix 
15.0 μl incubation mix 
  5.0 μl 5x M-MLV reaction buffer 
1.25 μl dNTP (10 mM)   
     1 μl RNase inhibitor RNasin (40 U/μl)  
     1 µl M-MLV-RT (200U/µl) 
ad 25μl with ddH2O  
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5.2.15 Quantitative Real Time PCR (qRT-PCR)  
Quantitative real-time PCR analysis was performed with the Opticon II PCR machine (MJ 
Research) and Opticon Monitor (Version 3.1.32) program using the Quantitect
TM
 SYBR
®
 
Green PCR kit. Gene-specific primers were selected with the program Primer 3.0 for product 
sizes of 200-400 bases. PCR was performed for 41 cycles at 95°C for 30 s (denaturation), 
57°C for 45 s (annealing) and 68°C for 40 s (elongation). As quantification standard defined 
concentrations of the annexin VII gene (Doring et al., 1995) were used for amplification. For 
normalization, the expression of GAPDH was used. The primers are shown in 4.1. 
 
Standard reaction set up (25 μl) 
  1.0 μl cDNA (1:10 diluted) 
  1.0 μl forward primer (10 pmol/μl) 
  1.0 μl reverse primer (10 pmol/μl) 
12.5 μl 2x SYBR Green PCR Mix 
  9.5 μl H2O 
 
5.3 Mammalian cell culture methods and transfections  
5.3.1 Cell culture and transfection 
HeLa were routinely cultivated in DMEM (Dulbecco’s Modified Eagle’s Medium) medium 
supplemented with fetal bovine serum (10%), penicillin (100 U/ml) and streptomycin (100 
μg/ml), L-glutamine (2 mM) and non-essential amino acids at 37°C and 5% CO2. Human 
wild-type and patients primary ﬁbroblasts were cultured in Eagle’s DMEM supplemented 
with 20% FBS (Biochrom), 1 mM glutamine, 1% penicillin/streptomycin, 7.5% sodium 
bicarbonate and 10 mM HEPES (pH 7.5) at 37°C and 5% CO2.  
Human wild-type ﬁbroblast cells were transfected by the CLB-Transfection™ System 
(Lonza) and HeLa cells were transfected by Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instructions. Cells transfected with plasmids were incubated for 24-48 h post-
transfection. 
 
5.3.2 Thawing cells 
To thaw cells stored in cryogenic tubes at -80°C or in liquid nitrogen, 9 ml of prewarmed 
medium was filled into a 15 ml falcon tube. The cells were resuspended with this medium and 
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transferred into 15 ml falcon tubes. Thereby the concentration of toxic DMSO was reduced 
from 10% in the freezing medium to 1% in the falcon tube. After centrifugation for 5 minutes 
at 1,200 rpm, the DMSO-containing supernatant was discarded and the cells resuspended in 
an appropriate amount of medium and distributed onto cell culture dishes.  
 
5.3.3 Freezing cells 
To freeze cells, the cells were trypsinized and centrifuged. The supernatant was discarded and 
the cell pellet was resupended in an appropriate amount (0.6-1 ml) of 1x freezing medium 
(20% FBS, 10% DMSO in medium). The cells were mixed with the freezing medium and 
transferred into a cryogenic tube. Cells were frozen at -80°C for a period of 2-3 weeks and 
then transferred to liquid nitrogen for longer storage. 
 
5.3.4 RNAi 
RNAi was performed as described (Turgay et al., 2014). Allstars negative control siRNA and 
SUN1 siRNA (5’-TTACCAGGTGCCTTCGAAA-3’) were purchased from QIAGEN and 
Microsynth, respectively. 5x10
3
 HeLa cells were seeded in 24-well plate for 
immunofluorescence analysis and 5x10
4
 HeLa cells were seeded in 6-well plate for Western 
blot analysis. RNAi transfection was performed at a final siRNA concentration of 20 nM per 
target gene using transfection reagent (INTERFERin, Polyplus) according to the 
manufacturer’s protocol. Cells were either fixed or harvested after 72 h transfection. For 
rescue experiments, HeLa cells were transfected with GFP-SUN1
R
 expression vector by 
Lipofectamine 2000 (Invitrogen) after 24 h siRNA treatment. Cells were processed for 
detection of poly(A)+RNA by in situ hybridization after 72 h siRNA treatment (Folkmann et 
al., 2013).  
 
5.4 Cell biological assays 
5.4.1 Cell proliferation, cell cycle and cell size measurements 
For cell proliferation analysis, 1x10
5
 cells of each patient and the wild-type were seeded at the 
same time. After every 48 h for a period of 6 days, cells were trypsinized and pelleted. After 
resuspending the cell pellets in 1 ml medium, cells were counted using a TC10™ Automated 
Cell Counter (Bio-Rad).  
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For cell cycle analysis, patient and wild-type cells were trypsinized and pelleted. After 
counting the cells, 5x10
5
 cells each were taken and 2 μl of cell permeable DNA specific dye 
Nuclear-IDTM Red DNA stain (Enzo life sciences) was added to the cell suspension (final 
concentration of 40 µM, 500 μl total volume). After incubation for 5 min at 37°C, the samples 
were analyzed by flow cytometry. The analysis was performed at the CMMC central 
facilities.  
For determination of the cell size, patient and wild-type cells were trypsinized and pelleted. 
Then cells were resuspended in PBS and transferred to the plates. Examination was done by 
using bright ﬁeld microscopy at 40x magniﬁcation. The size of 400 cells per strain was 
determined. 
 
5.4.2 Senescence-associated β-galactosidase assay 
Cells were seeded on coverslips one day before the assay was performed, washed with PBS 
and ﬁxed with 2% (v/v) formaldehyde or 0.2% (w/v) glutaraldehyde (dissolved in PBS) (5 
min, RT). Cells were washed three times with PBS and incubated with freshly prepared 
senescence-associated-Gal (SA-Gal) staining solution (van der Loo et al., 1998) for 6 to 8 h at 
37°C without CO2. The stained cells were imaged under bright ﬁeld microscopy at 40x 
magniﬁcation.  
 
SA-β-Gal staining solution 
    1 mg/ml 5-bromo-4-chloro-3-indolyl β-D-galactoside (X-Gal) 
  40 mM citric acid/sodium phosphate, pH 6.0 
    5 mM potassium ferrocyanide K4Fe(CN)6 
    5 mM potassium ferricyanide K3Fe(CN)6 
150 mM NaCl  
2 mM MgCl2 
 
5.4.3 Heat stress experiment 
Wild-type and patient ﬁbroblasts were seeded on 12 mm glass coverslips two days before the 
experiment and cultured at 37°C. For heat stress, cells were placed in a 45°C incubator for 30 
min and ﬁxed immediately after treatment with cold methanol at -20°C for 5 min, and then 
incubated with rabbit polyclonal anti-Lamin A/C antibodies to detect the nuclear envelope 
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and pericentrin speciﬁc polyclonal antibodies to detect the centrosome. Untreated wild-type 
and patient fibroblasts were used as control. 
 
5.4.4 Cell migration analysis and wound-healing assay 
Cell migration was studied by performing wound-healing assay using specific wound assay 
chamber (Ibidi, Munich, Germany). Cells were seeded at a density of 4x10
4
 cells on each side 
of an Ibidi culture insert for live cell analysis and allowed to grow for 24 h. Inserts were then 
removed with sterile forceps to create a 500 μm space between the cells on each side of the 
well and incubation with fresh culture medium was continued. The cell migration into the 
defined cell free gap was followed over 20 h by live cell imaging using Leica DM IRE2 
microscope. For analysis of single cell migration, cells were followed using the manual 
tracking software component of the Image J program. After tracking, the cell paths were 
analyzed using the “Chemotaxis and Migration Tool”. 
 
5.5 Immunological and protein chemical methods 
5.5.1 Immunoﬂuorescence 
Cultured cells grown on coverslips were ﬁxed in 4% paraformaldehyde in PBS for 10 min 
followed by permeabilization with 0.5% Triton X-100 for 5 min for primary antibody 
staining. Alternatively, cells were ﬁxed in cold methanol (-20°C) for 10 min. Subsequently, 
the fixed cells were washed three times with 1x PBS and incubated for 15 minutes with PBG 
blocking solution. After blocking, primary antibodies were diluted in PBG and incubated with 
the cells for 1 h at RT or overnight at 4°C. Subsequently the samples were washed three times 
(5 min each) with PBS and then incubated with required secondary antibodies (1:1.000 
diluted in PBG) conjugated with Alexa Fluor 488 , Alexa Fluor 568, Cy3, TRITC or FITC for 
one hour at RT. The nuclear DNA was counterstained with DAPI (4’,6-Diamidino-2’-
phenylindole), and the coverslips were mounted on glass slides with gelvatol. The stained 
cells were analyzed using confocal laser scanning microscopy (TCS-SP5, Leica).  
 
Gelvatol  PBG (pH 7.4) 
4.8 g Polyvinyl alcohol (87%-89%)  5% BSA 
 12 g Glycerol 0.45% fish gelatine 
+ 12 ml de-ionized water, stir (RT, 10 h)  PBS 
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+ 24 ml 0.2 M Tris/HCl, pH 8.5 
stir (50°C, 20-40 min)  
 
cenrifugation (15 min, 5000 g)  
1.3 g Diazabicyclooctane (DABCO)                                                 
Aliquot-storage: – 20°C  
 
5.5.2 Protein lysates from mammalian cells and western blotting 
Cells grown to 80% conﬂuency were trypsinized and pelleted down in 15 ml centrifuge tube. 
After washing with PBS, the cells were resuspended in modiﬁed radio-immunoprecipitation 
(RIPA) lysis buffer. Cell suspensions were passed through a 0.45 µm needle for 10 times and 
incubated for 15 min on ice, followed by 10 sec sonication. The lysates were cleared by 
centrifugation at 12,000 rpm for 10 min at 4°C. The supernatant of total cell lysates can be 
either directly heated in 5x SDS sample buffer (95°C, 5 min) for western blot analysis or 
incubated with GST fusion protein-coupled beads for pulldown experiment (described in 
5.5.6). 
For western blot analysis, proteins were resolved in 10%, 12% or 3–15% gradient SDS-PAGE 
and transferred to PVDF membrane with wet blot transfer buffer at 15 V for overnight or 48 h 
at 4°C. Transfer efficiency was confirmed by Ponceau staining. After blocking with 5% milk-
powder in 1x NCP, the membrane was incubated with primary antibody diluted in 1x NCP 
buffer for 1 h at RT or overnight at 4°C. Following three washings, the secondary antibody 
(1:10,000) coupled with horseradish peroxidase (POD) was added for 1 h incubation. The 
membrane was washed again with 1x NCP and the signals were detected by using enhanced 
chemiluminescence (ECL) system. 
RIPA lysis buffer 5x SDS loading buffer 
50 mM Tris/HCl, pH 7.5 3.12 ml 1M Tris/HCl, pH 6.8 
150 mM NaCl 10 ml 10% SDS 
1% NP-40 5 ml Glycerol 
0.5% Na-desoxycholate 2 ml ß-Mercaptoethanol 
Just add before use Pinch of Bromophenol blue 
1 mM dithiothreitol (DTT)  
1 mM benzamidine  
1 mM PMSF  
Protease inhibitor cocktail  
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5.5.3 Subcellular fractionation 
After RNAi transfection, HeLa cells were processed for subcellular fractionation as described 
(Suzuki et al., 2010). The cells grown in 6-well plate were washed, trypsinized and 
centrifuged in 1.5 ml centrifuge tubes (1000 rpm, 5 min at 4°C). After removing the 
supernatants, the cell pellets were resuspended in 450 μl fractionation buffer and triturated 5 
times using a p1000 micropipette. Afterwards 150 μl of the lysate was removed and kept as 
the “whole cell lysate”. The rest samples were centrifuged with a table top microfuge (~10 
sec), and then the supernatants were kept as the “cytosolic fraction”. Next the pellets were 
washed with fractionation buffer again and centrifuged as above. After removing the 
supernatants, the pellets were resuspended in 150 μl fractionation buffer and designated as the 
“nuclear fraction”. Finally, the “whole cell lysates” and the “nuclear fractions” were sonicated 
and heated along with the “cytosolic fraction” at 95°C for 5 min. Samples were resolved by 
SDS-PAGE and analyzed by western blotting with appropriate antibodies. 
 
Fractionation buffer (freshly prepared on ice) 
 0.1% NP-40 dissolved in 1x PBS 
 
5.5.4 Co-immunoprecipitation (Co-IP) 
Precipitation by GFP polyclonal antibodies Wild-type fibroblasts were transfected with 
plasmids GFP-SUN1, GFP-SUN1A203V or GFP-SUN1A614V. The next day cells were 
scraped into RIPA buffer (50 mM Tris/HCl, pH 7.5, 50 mM NaCl, 1% NP-40, 1% Na-
Transfer buffer      Ponceau staining solution                                     
43.2 g Glycine        0.5 g Ponceau S 
9 g Tris    5 ml Acetic acid 
ad ddH2O to make 3 L ad ddH2O to make 0.5 L                                          
  
ECL solution  10x NCP buffer  
2 ml 1 M Tris/HCl, pH 8.0 100 ml Tris/HCl, pH 8.0 
200 μl 0.25 M Luminol in DMSO 87.5 g NaCl 
89 μl 0.1 M p-coumaric acid in DMSO 6 ml Tween-20                                                                                                    
20 ml dH2O ad ddH2O to make 1 L 
6.3 μl 30% H2O2  
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deoxycholate) supplemented with 1 mM DTT, Benzamidine, PMSF and protease inhibitor 
cocktail (Roche), followed by sonication and centrifugation at 16,000 g and 4°C for 10 min. 
Lysates were precleared with protein A Sepharose (GE Healthcare) for 1 h and then incubated 
with 2 μg of antibody for 2 h at 4°C. Antibodies were precipitated by addition of protein A 
Sepharose for a further 1 h, pelleted at 1,000 g, and then washed in lysis buffer minus 
protease inhibitors. Samples were heated in SDS sample buffer (95°C, 5 min) and analyzed 
using 12% SDS -PAGE.  
Precipitation by GFP-Trap beads Human fibroblasts cells were transfected with GFP, GFP-
SUN1 or GFP-SUN2 encoding plasmids. The next day cells were scraped into lysis buffer (10 
mM Tris/HCl, pH 7.5, 50 mM NaCl, 0.5 mM EDTA, 0.5% NP-40) supplemented with 1 mM 
DTT, Benzamidine, PMSF and protease inhibitor cocktail (Roche), followed by sonication 
and centrifugation at 16,000 g and 4°C for 10 min. Lysates were precleared with protein A 
Sepharose (GE Healthcare) for 1 h and then incubated with GFP-Trap beads (Chromotek) for 
2 h at 4°C. Beads were pelleted at 1,000 g, and then washed several times with lysis buffer 
minus protease inhibitors. Samples were heated in SDS sample buffer (95°C, 5 min) and 
analyzed using 12% SDS-PAGE.  
 
5.5.5 Purification of recombinant proteins from E. coli 
For expression of recombinant proteins, a 20 ml pre-culture of LB-medium with appropriate 
antibiotics was inoculated with XL1-Blue or ArcticExpress RIL E. coli cells transformed with 
target plasmids and incubated at 37°C overnight with shaking at 220 rpm. The main-culture 
(500 ml) was inoculated at a ratio of 1/50 with the pre-culture and incubated at 37°C until the 
cells reached a density of OD600 ~ 0.5-0.6. Afterwards the recombinant protein expression 
was induced with 0.5-1 mM IPTG for 4 hours at 37°C or overnight at room temperature. 
Alternatively, the ArcticExpress RIL E. coli culture was incubated at 10°C for 24 h. Then, the 
cells were harvested by centrifugation at 6,000 g for 10 min and resuspended in 20 ml lysis 
buffer or frozen at –20°C for future use. After sonification (30 % amplitude, 15 s pulse, 10 s 
break, time 5 min), the soluble fraction of the bacterial lysate was obtained by centrifugation 
at 20,000 g for 30 min (4°C). The GST fusion protein was isolated from the supernatant by 
incubation with 300 μl of washed Glutathione Sepharose 4B beads (GE-Healthcare) under 
shaking for 3 hours or overnight at 4°C. And then the beads coupled with GST fusion proteins 
were washed 5 times with washing buffer. The purified GST fusion proteins were either 
directly used for pulldown experiment or incubated with cleavage buffer and specific enzyme 
(24-48 h, 4 °C) to remove the GST tag. 
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Washing buffer 
  50 mM Tris/HCl, pH 8.0 
150 mM NaCl 
 
 
 
 
 
PreScission protease cleavage buffer  
  50 mM Tris/HCl, pH 7.4 
150 mM NaCl 
    1 mM EDTA 
    1 mM DTT 
Bacterial lysis buffer 
washing buffer  
Ad just before use  
1 mM DTT 
1 mM Benzamidin 
1 mM PMSF  
protease inhibitor 
 
Thrombin cleavage buffer 
  50 mM Tris/HCl, pH 8.0 
150 mM NaCl 
  10 mM CaCl2 
 
 
5.5.6 GST pulldown assay 
Expression of recombinant GST-CT-Lamin A/C, GST-SUN2-NT and GST-NXF1 
polypeptide was induced in E. coli strain XL1-Blue. GST-SUN1-NT and all GST-Nup153 
fragments polypeptide were induced in ArcticExpress RIL. Cells were lysed and the fusion 
proteins were isolated as described in 5.5.5. After several washing steps, the purified GST 
fusion proteins were incubated with human fibroblast or HeLa total cell lysates (lysate 
preparation is described in 5.5.2) for 1.5-3 h at 4°C. GST alone was used as negative control. 
Beads coupled with protein complexes were washed 3 times with RIPA buffer (500 g, 4°C, 1 
min) and heated in 5x SDS sample buffer (95°C, 5 min). Samples were analyzed using 12% 
SDS-PAGE followed by western blotting. 
 
5.5.7 Poly(A)+RNA isolation-Oligo (dT) pulldown assay 
1.5x10
7
 HeLa cells were harvested for nuclear poly(A)+RNA immunoprecipitation essentially 
as described (Wickramasinghe et al., 2010), except Dynabeads
®
 Oligo (dT)25 were used 
instead of oligo(dT) cellulose. Briefly, the harvested HeLa cell pellet was washed in 1ml ice 
cold PBS and centrifuged at 1000 rpm for 2 min. The pellet was suspended in 1 ml PBS 
homogenization buffer and homogenized using a glass homogenizer (tight pestle). The 
nuclear fraction was isolated after 10 min centrifugation (2000 g, 4°C). After removing the 
supernatant (cytoplasmic fraction), the pellet was lysed in 450 µl PBS lysis buffer with 3 
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times (5 sec each) sonication and 10 min centrifugation (2000 g, 4°C) afterwards. The 
resulting supernatant was the soluble nuclear extract. Then the Dynabeads
®
 Oligo (dT)25 and 
0.05% NP-40 were added and incubated with nuclear extract for 45 min at 4°C with gentle 
rotation. The Poly(A) + RNA was isolated after washing the beads thoroughly for 3 times 
(500 µl each) with PBS lysis buffer plus 0.1% NP-40 by placing on the magnet at room 
temperature. Samples were analyzed by SDS-PAGE followed by western blotting with 
relevant antibodies. 
 
PBS homogenization buffer PBS lysis buffer 
137 mM NaCl 137 mM NaCl 
    3 mM KCl     3 mM KCl 
    8 mM Na2HPO4     8 mM Na2HPO4 
    2 mM NaH2PO4, pH 7.2     2 mM NaH2PO4, pH 7.2 
Just add before use  Just add before use  
0.2% NP-40  100 µg/ml PMSF  
100 µg/ml PMSF  5 mM vanadyl ribonucleoside complex  
 0.2 U/μl of RNase OUT (Invitrogen)  
 
5.5.8 In situ hybridization 
HeLa cells were cultured and processed as described (Folkmann et al., 2013). To localize 
poly(A)+RNA in HeLa cells, 5x10
3
 cells were seeded in 24-well plate and fixed after 72 h 
RNAi transfection. For Leptomycin B (LMB) treatment, HeLa cells were treated with LMB at 
a final concentration of 7ng/ml (37°C, 2 h) after 72 h RNAi transfection. After fixation with 
4% PFA for 15 min, the cells were permeabilized by 0.2% Triton X-100 in PBS for 5 min 
(RT). Between each step, the cells were washed 3 times (5 min each) with PBS. Then pre-
hybridization was performed by incubating the cells with prehybridization buffer at 37 °C for 
1h (in a tissue culture incubator). Then the poly(A)+RNA was localized by hybridization with 
diluted Cy3-conjugated Oligo d(T)50 probe (1ng/μl) in prehybridization buffer at 37°C for 2 h 
(in tissue culture incubator). A series of washing steps followed afterwards. Washing was for 
3 times (10 min each) in 2x SSC buffer at 37°C, 3 times (10 min each) in 1x SSC buffer at RT 
and 3 times (5 min each) in 1x PBS. The nuclear DNA was stained with DAPI diluted in 0.2% 
Triton X-100/PBS for 30 min at RT. The cells were washed in PBS and mounted with 
gelvatol. Images were acquired using confocal laser scanning microscopy (TCS-SP5, Leica) 
and processed with LAS AF Lite software (Leica). The mean Cy3 intensity was determined 
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for the nuclear and cytoplasmic distribution of 500 individual cells under each condition. 
Nuclear/cytoplasmic (N/C) ratios were calculated and plotted on line graphs for the indicated 
conditions.  
 
Pre-hybridization buffer  20x SSC 
(Prepare before use, for 1 ml) 175.32 g Sodium chloride  
 2.5 µl tRNA (50 mg/ml)       88.23 g Sodium citrate  
  50 µl herring sperm DNA (10 mg/ml) ad ddH2O to make 1 L 
100 µl SSC (20x) adjust pH to 7.0 
  50 µl BSA (20 mg/ml)   
500 µl formamide  
    5 µl vanadyl ribonucleoside complexes (200 mM)  
 0.1 g dextran sulfate  
289.5 µl ddH2O   
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6. Appendix 
Table 1: Characteristics of patient fibroblasts 
Characteristics P1 P2 
 
Laminopathy 
associated 
trait 
 
SUN1 
associated 
trait 
Reference 
 
Proliferation 
 
↓ ↑ ↓ ↓ 
(Chen et al., 2012; 
Pratt et al., 2011) 
Cell cycle distribution 
Less M-
phase cells 
* 
Normal 
Anaphase 
delay 
 
Sun1-/-Sun2-/-
Less cells in 
G2/M, S phase 
arrest 
 
(Lei et al., 2012; 
Pratt et al., 2011) 
 
Cell size 
 
↑*** Normal Nuclear size↑ - (Pratt et al., 2011) 
 
Centrosome-nucleus 
distance 
 
↑* ↓* ↑* - 
(Hale et al., 2008)  
(Taranum et al., 
2012) 
Senescence-associated 
β-galactosidase 
↑*** ↑* ↑** - 
(Chen et al., 2012; 
Le Dour et al., 
2011; Taranum et 
al., 2012)  (Ho et 
al., 2011) (Benson 
et al., 2010) 
 
Sensitivity towards 
heat shock 
 
↑ ↑ ↑ - 
(Taranum et al., 
2012) (Paradisi et 
al., 2005) 
Single cell motility ↑** Normal ↓ - 
(Chancellor et al., 
2010; Lee et al., 
2007; Taranum et 
al., 2012) 
 
Lamin B1 protein 
level 
 
↓** Normal ↓ - (Liu et al., 2011) 
 
SUN1 protein level 
 
↓** ↓* - - - 
 
SUN2 protein level 
 
Normal ↑*** - - - 
 
LAP2 protein level 
 
↓*** ↓*** ↓ - (Liu et al., 2011) 
 
Nesprin-2 protein 
level 
 
↓** Normal - - - 
 
Interaction between 
LaminA/C and SUN1 
 
↓** ↓** - - - 
*Significance: *p < 0.05, **p < 0.01, ***p < 0.001. 
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Table 2: Characteristics of wild-type fibroblasts expressing wild-type and mutant SUN1 
proteins in immunofluorescence  
 
Characteristics 
 
SUN1 SUN1-A203V SUN1-A614V 
Lamin A/C 
 
Localization 
 
Nuclear envelope Nuclear envelope Nuclear envelope 
 
Expression 
 
Normal Normal Normal 
Lamin B1 
 
Localization 
 
Nuclear envelope Nuclear envelope Nuclear envelope 
 
Expression 
 
Normal Normal Normal 
Emerin 
 
Localization 
 
Nuclear envelope and 
aggregates 
Nuclear envelope and 
aggregates 
Nuclear envelope and 
aggregates 
 
Expression 
 
↓ ↓ ↓ 
SUN2 
 
Localization 
 
Nuclear envelope Nuclear envelope Nuclear envelope 
 
Expression 
 
↓ ↓ ↓ 
LAP2 
 
Localization 
 
Nuclear envelope and 
dots 
Nuclear envelope and 
dots 
Nuclear envelope and 
dots 
 
Expression 
 
↓ ↓ ↓ 
 
Interaction with Emerin 
 
Normal ↓ ↓ 
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7. Abbreviations 
ATP     Adenosine triphosphat 
bp     Base pair(s) 
cDNA     Complementary DNA 
CT     C-terminus 
Da     Dalton 
DAPI     4’-6-diamidino-2-phenylindole 
DMSO     Dimethyl sulfoxide 
DNA     Deoxyribonucleic acid 
dNTP     Deoxynucleoside triphosphate 
DTT     Dithiothreitol 
E. coli      Escherichia coli  
EDTA     Ethylene diamine tetraacetic acid 
FBS     Fetal bovine serum 
Fw     forward 
g     Gramm 
g     Relative centrifugation force 
GAPDH    Glycerinaldehydephosphate dehydrogenase 
GFP     Green fluorescent protein 
GST     Glutathione S-transferase 
h     Hour (s) 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IgG     Immunglobulin G 
IPTG     Isopropyl-β-Dithiogalactopyranoside 
kb     Kilobases  
KD     Knock down 
kDa     kilodalton 
LAP     Lamina-associated polypeptide 
LC-MS    Liquid chromatography–mass spectrometry 
MDa     Mega Dalton 
min     Minute (s) 
mM     Millimolar 
mRNA     messenger ribonucleic acid 
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NP-40     Nonidet P-40 
NT     N-terminus 
OD     Optical density 
PBS     Phosphate buffered saline 
PCR     Polymerase chain reaction 
PFA     Paraformaldehyde 
pH     negative decadic logarithm of protein concentration 
PIC     Proteinase inhibitor cocktail 
PMSF     Phenylmethanesulfonyl fluoride 
PVDF     Polyvinylidene difluoride 
qRT-PCR    Quantitative real time PCR 
RIPA     Radioimmunoprecipitation assay 
RNAi     RNA interference 
rpm     Rotation per minute 
RT     Room temperature 
Rv     Reverse 
SD      Standard deviation 
SDS-PAGE   Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Sec     Second (s) 
siRNA     Small interfering RNA 
SSC      Saline-sodium citrate 
TAE     Tris-Acetate-EDTA 
Taq     Thermophilus aquaticus 
TE     Tris-EDTA 
TEMED    N,N,N’,N’-Tetramethylethylendiamine 
Tris      Tris (hydroxymethyl) aminomethane  
tRNA      Transfer-RNA 
μg     Microgram 
μl     Microliter 
μM     Micromolar 
UV     Ultraviolet light 
WB     Western blot 
WT     Wild type  
X-gal     5-bromo-4-chloro-3-indolyl-D-galactopyranosid 
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